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Depression and anxiety affect more Americans than any other mental illness. 
Although effective treatments are available, treatment is often inadequate, delayed, or absent 
altogether. Individuals with depression or anxiety and groups at risk of developing these 
problems face a range of barriers to appropriate treatment, including difficulties obtaining 
health insurance, limitations in coverage for mental health services, and challenges accessing 
specialized care relative to general medical care. Recent policies aimed to improve access to 
mental health care by expanding insurance coverage, improving fairness in insurance 
benefits, and strengthening services in general medical settings. 
The objectives of this dissertation were to examine: 1) the impact of insurance 
expansion on mental health care among individuals with depression and anxiety, including 
changes that may signal adverse selection; 2) the association between insurance benefits 
reform and mental health care among individuals with depression and anxiety; and 3) the 
correlates of depression care and the role of screening in diagnosis and treatment among 
outpatient primary care visits. 
The first study estimated changes in the probability and quantity of mental health 
service use and total and out-of-pocket spending among young adults and a separate sample 
of new enrollees after the dependent coverage provision (DCP) of the Affordable Care Act 
was implemented. The DCP was associated with increased service use and spending without 
higher intensity service use by new enrollees, suggesting those who gained coverage needed 
treatment but not at higher levels.  
The second study estimated changes in the probability and quantity of mental health 
service use and total and out-of-pocket spending among young adults after the Mental 
Health Parity and Addiction Equity Act (MHPAEA) was implemented. The MHPAEA was 
 iii 
associated with small shifts in service use without increased financial protection, suggesting 
modest changes in this population that were attributable to the policy. 
The third study assessed the correlates of depression screening, diagnosis, and 
treatment in representative primary care settings and estimated the relationship between 
screening rates and the probability of diagnosis and treatment. Patterns of depression care 
suggested that physicians focused on high-risk patients. Additionally, higher screening rates 
were associated with higher rates of depression identification and treatment.  
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CHAPTER ONE: INTRODUCTION 
  
 2 
Rationale for Research 
Background 
Depression and anxiety are the most common mental disorders affecting Americans. 
In a given year, more than one in five adults will experience any anxiety disorder and about 
one in ten will experience depression [1]. Over their lifetimes, more than one third of adults 
will experience any anxiety disorder and about one in five will experience depression [1]. In 
addition, a large proportion of people experience depression and anxiety disorders 
simultaneously [2, 3]. Effective treatments are available to address these high prevalence 
rates, yet many individuals with depression or anxiety are untreated [4].  
People who ultimately receive treatment for depression and anxiety often experience 
long delays between the onset of their symptoms and initial contact with mental health care 
[5]. Furthermore, individuals who develop depression and anxiety at younger ages are less 
likely to make treatment contact in their lifetime than those who develop a disorder later, 
possibly because barriers to care are exacerbated among young people and alternative coping 
mechanisms inhibit future treatment seeking [5]. The association between early onset and 
low treatment rates is particularly important considering both depression and anxiety 
typically emerge early in the life course and often recur, which can lead to persistent negative 
outcomes [6].  
At the population level, depression and anxiety disorders are the leading contributors 
to mental health and substance use-related morbidity [7]. Depression and anxiety disorders 
are also associated with increased mortality, although most people die from the same 
physical causes as people without mental illness [8]. This disparity in the risk of death 
between individuals with and without mental illnesses can be explained by clinical, health 
system, and socioeconomic factors combined, but health status has the largest effect [9]. 
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From a public health perspective, this finding highlights the importance of health system 
factors, including insurance coverage and access to care [9].  
Expanding Access to Commercial Health Insurance Coverage   
Young adulthood is a vulnerable period not only for developing depression and 
anxiety, but also for experiencing insurance problems [6, 10]. Over 40% of young adults 19-
25 years old reported any prior-year uninsurance in 2010, the year the Affordable Care Act 
(ACA) was enacted [11]. Despite conceptions that young adults forgo health insurance out 
of a belief they do not need coverage, evidence shows that most young adults with access to 
insurance through an employer or family member enroll in coverage when it is affordable 
[12, 13]. By allowing young adults to maintain insurance through a parental plan until they 
turn 26 years old, the ACA’s dependent coverage provision (DCP) expanded access to 
private health insurance. At that time, insurers commonly restricted coverage for dependents 
through age 18 or upon graduation from high school or college for full-time students [14]. 
While some states had passed laws extending coverage to older dependents, many insurers 
were exempt from state regulations and most laws included at least one exclusion based on 
marital status, residency outside the parent’s home, or having their own children [14]. 
Beginning September 23, 2010, the DCP required private plans to insure dependents 
regardless of these other factors.   
Many young adults gained private insurance coverage through this mechanism [15-
21]. As a result of higher coverage rates, studies also indicated young adults experienced 
increased access to care. Young adults were less likely to report delaying care and more likely 
to report having a routine check-up following the provision than before it was implemented 
[16, 21]. Direct measures of young adults’ health care found increases in health service 
utilization, particularly in inpatient and emergency settings [15, 17]; however, results for 
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mental health and substance use services were mixed, with some studies finding increases in 
hospital-based care and others finding decreases [15, 18, 19, 22, 23]. Published research to 
date has not studied the privately insured young adult population, a critical group for 
understanding the relationship between dependent coverage expansion and changes in the 
pool of enrollees. Increased access to private coverage could have led to adverse selection 
whereby young adults who needed mental health services took advantage of the new option 
at higher rates than young adults without mental illness. Early research explored possible 
selection effects by examining the relationship between self-reported health and insurance 
coverage but the results differed [16, 24]. One study found larger initial gains in insurance 
coverage among those reporting worse health, while the other found no differences in 
coverage by health status [16, 24]. Neither study explicitly considered mental health.  
The first manuscript assessed how mental health service use and spending among 
privately insured young adults diagnosed with depression and anxiety changed after 
implementation of the DCP. First, the overall impact of the DCP on outcomes among 
young adults was analyzed. Then, outcomes among newly enrolled young adults were 
analyzed to assess whether those who first gained access to insurance after the policy 
demonstrated patterns of mental health service use that were consistent with the level of 
services utilized by new enrollees in insurance plans and to evaluate these utilization and 
spending patterns in relation to changes observed in the overall sample. This approach was 
aimed at understanding whether changes among the broader group reflected new access to 
insurance coverage or whether young adults who gained coverage after the policy received 
treatment at higher rates and for more chronic or serious problems relative to all new 
enrollees, a change in the composition of the insured populations that could be indicative of 
selection. The results from both analyses have important implications regarding the 
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distribution of financial risk associated with mental health care and future efforts aimed at 
improving access to care for young adults. 
Improving Equity in Health Insurance Benefit Design  
Health coverage alone does not ensure access to care. In fact, many young adults 
with insurance are underinsured, reporting that needed treatment was delayed or missed 
altogether because of costs [12]. In one study of the correlates of mental health care 
utilization among a sample young adults who perceived a need for mental health treatment, 
service use was associated with membership in a family with more financial resources despite 
the fact that nearly all young adults studied were covered by health insurance [25]. These 
results indicate that out-of-pocket costs can present barriers to mental health care among 
insured young adults, particularly with respect to their wider financial considerations.  
In the past, cost sharing was often set at higher rates for mental health than medical 
services. Mental health benefits were more restrictive than medical benefits in other ways, 
for example, in terms of the limits placed on the number of services covered in a given time 
period. Before the proliferation of managed care techniques to contain costs, insurers 
justified applying more restrictive measures to mental health benefits because mental health 
care utilization was shown to be more responsive to price [26]. By increasing the effective 
cost of mental health services paid by beneficiaries, insurers could control the total costs 
accrued for mental health care. Managed care techniques can also contain costs, and studies 
showed that implementing parity between mental health and medical/surgical benefits in 
plans with managed behavioral health care could achieve improvements in financial 
protection for beneficiaries without considerable spending increases overall, substantially 
weakening the rationale for disproportionate mental and medical/surgical benefit structures 
based on total spending [27]. 
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 After decades of research and advocacy, the Mental Health Parity and Addiction 
Equity Act (MHPAEA) of 2008 was passed in order to ameliorate inequities in insurance 
design. The MHPAEA required large group insurance plans that offered mental health 
coverage to provide mental health and substance abuse benefits equivalent to medical and 
surgical benefits [28]. The MHPAEA improved upon the previous Mental Health Parity Act, 
a 1996 law prohibiting discrimination in spending limits, by encompassing substance abuse 
services in addition to mental health care and by extending parity requirements to cost 
sharing provisions, treatment limits, benefits for services from participating providers and 
out-of-network care, and other nonquantitative care management practices [29]. Studies have 
identified associations between implementation of the MHPAEA and reductions in cost-
sharing requirements and annual limits for mental health services [30-33]. Evidence has also 
shown an association between implementation of the MHPAEA and improvements in 
access to care and financial protection for enrollees, with most studies showing increased 
mental health service use without increased out-of-pocket spending [34-37]. No existing 
studies of the MHPAEA focused on depression or anxiety disorders; however, analyses of 
parity implemented in health plans for federal employees show promising results among 
individuals with depression, separately finding decreases in out-of-pocket spending with 
steady service utilization and some improvements in guideline-concordant depression 
treatment [38, 39]. Research has not specifically examined the impact of the MHPAEA 
among young adults who have elevated risk of mental illness and insurance problems. 
To address this gap, the second manuscript analyzed the association between 
implementation of the parity law and mental health service use and spending among young 
adults with depression and anxiety diagnoses. Utilization and spending for inpatient and 
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outpatient mental health services were measured to assess whether the benefits of the federal 
parity law extended to a high-risk group of individuals who have common mental illnesses. 
Screening, Diagnosis and Treatment for Depression in Primary Care Settings  
By design, primary care is the main entry into the health system [40]. Consequently, 
general medical providers rather than specialty mental health providers encounter and care 
for many patients with depression and other mental illnesses [41, 42]. Although effective 
psychological and pharmacological options are available to reduce symptoms and promote 
remission in primary care settings, most primary care patients with depression receive no 
treatment at all [4, 41, 43]. Lack of treatment can largely be explained by low rates of 
depression identification in primary care settings [43]. When depression is diagnosed and 
treated, psychotherapy and medication management often fail to meet evidence-based 
guidelines [41].  
Coordinated and collaborative care interventions have demonstrated success 
integrating higher quality depression care into general medical settings, but important 
challenges remain [44]. From a research perspective, the relative effect of specific 
intervention components within comprehensive programs is difficult to isolate and mixed 
research results from program evaluations highlight the potential importance of contextual 
influences, including the organizational environment in which the program is implemented 
[44]. From a practical perspective, integrating mental health treatment into primary care is 
limited by financial barriers and other resource constraints, such as mental health workforce 
shortages [44-47]. Considering most primary care settings are practices with only one 
physician or physicians in small group practices, a better understanding of care patterns 
across contexts is needed to distinguish the elements of depression treatment that are 
feasible to implement and likely to succeed in conventional settings [48, 49].  
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Systematic evidence reviews have established the basis for recommendations and 
policy incentives to screen adolescents and adults for depression in general medical settings 
[50, 51]; however, critics of the recommendations have questioned the quality of the 
evidence, the applicability to typical settings, and the ultimate tradeoffs associated with 
universal depression screening programs [52-56]. In practice, depression screening in 
primary care settings is rare, despite physicians’ reporting uncertainty about diagnosing 
depression and acknowledging that screening is helpful [51, 57-59]. These apparent 
discrepancies highlight that evidence is lacking about the role of screening in the pathway to 
depression diagnosis and treatment in representative outpatient settings.  
The third manuscript examined the correlates of depression screening, diagnosis, and 
treatment in representative primary care settings to characterize patterns of care. A separate 
analysis considered the potential implications of higher screening rates for depression 
diagnosis and treatment outcomes, using a simulation approach to examine how higher 
screening might affect these outcomes. Given the recent acceleration toward new and 
evolving delivery and payment systems that emphasize primary care, identifying key features 
of clinical encounters between patients and providers can help inform the evidence base to 
strengthen depression care in primary care settings, including potentially increasing diagnosis 
and treatment rates. 
Study Aims 
This research was motivated by recent policy efforts to improve access to higher 
quality mental health care. The broad objective was to examine mental health services in the 
context of three dimensions of access to care [60]. First, health policy that expands the 
availability and affordability of insurance can enhance potential access to care through 
financial protection against treatment costs. Second, insurance reform that explicitly 
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addresses the needs of vulnerable, stigmatized, and disadvantaged groups can improve 
equitable access to care. Finally, the relationships between health services and individual and 
contextual characteristics can reveal patterns to explain differences in realized access to care, 
or service use. The first two studies focused on young adults, who have increased risk of 
experiencing mental health and insurance problems. The third study focused on general 
medical settings, where mental health care is common but inadequate.  
Aim 1 – Examine the impact of the dependent coverage provision (DCP) of the Affordable 
Care Act on mental health service use and spending among young adults diagnosed with 
depression and anxiety, including changes in the composition of the population in treatment 
that may indicate selection effects 
Aim 2 – Examine the association between the Mental Health Parity and Addiction Equity 
Act (MHPAEA) and mental health service use and spending among young adults diagnosed 
with depression and anxiety 
Aim 3 – Examine the correlates of depression care and the role of screening in depression 
diagnosis and treatment among visits by adolescents and adults to outpatient primary care 
settings 
Dissertation Organization 
 The dissertation is organized into three empirical chapters with tables and figures 
incorporated and a concluding chapter. Chapter Two presents a study of the impact of 
dependent coverage expansion on mental health service use and spending among young 
adults with depression and anxiety diagnoses compared to older young adults who were not 
targeted by the ACA provision, including whether service use and spending were indicative 
of adverse selection. Chapter Three examines the association between the federal parity law 
and mental health service use and spending among young adults with depression and anxiety 
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diagnoses. Chapter Four describes the role of depression screening in diagnosis and 
treatment among visits to outpatient primary care settings by adolescents and adults. Chapter 
Five reviews and discusses the findings and the implications for policy and future research. 





CHAPTER TWO: MANUSCRIPT ONE 
 
 
The impact of the dependent coverage provision of the Affordable Care Act on mental 
health service use and spending among young adults with depression and anxiety 
 
 
Hillary Samples, MHS 
 
Johns Hopkins Bloomberg School of Public Health 




Objective: The purpose of this study was to examine the impact of the dependent coverage 
provision (DCP) of the Affordable Care Act (ACA) on mental health service use and 
spending among young adults, including changes potentially induced by shifts in the young 
adult insurance pool. Service use and spending were assessed among young adults covered 
by private health insurance who had depression and anxiety diagnoses.  
Methods: Insurance claims were extracted from the MarketScan database, which included 
enrollees in large employer-sponsored plans before (2007-2009) and after (2011-2012) 
implementation of the DCP. Difference-in-difference models assessed the impact of the 
DCP, comparing changes over time between young adults 19-25 years old and adults 27-33 
years old who were not targeted by the policy. To test changes in the pool of privately 
insured young adults, a separate sample of new enrollees was analyzed, defined as individuals 
within the same age groups who were in their first year of continuous enrollment in a plan. 
Outcomes were depression and anxiety-related inpatient and outpatient services, outpatient 
psychotherapy and medication management, and total and out-of-pocket mental health 
spending.  
Results: Implementation of the DCP was associated with increases in the probability of 
young adults using all inpatient and outpatient services, the number of outpatient depression 
or anxiety and psychotherapy services used, and total and out-of-pocket spending relative to 
the comparison group of 27-33 year old adults not eligible for coverage under the DCP. 
New enrollees showed similar increases in the probability of using services and spending, but 
fewer increases in the number of services used relative to changes in the overall sample. 
Conclusions: Increases in mental health service use among young adults with depression 
and anxiety diagnoses suggest the DCP was associated with increased access to care among 
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those enrolled in large employer-sponsored insurance plans. Young adults who enrolled in 
insurance after implementation may have had previously unmet treatment needs or 
disproportionately higher rates of depression and anxiety, but they showed similar treatment 





Depression and anxiety disorders are the most common mental health problems 
experienced by Americans [1]. Effective treatments that reduce symptoms and promote 
remission are available, but many people with a disorder remain untreated [4, 5]. Recent 
insurance reform efforts were aimed at addressing under-treatment of health problems, 
including common mental illnesses like depression and anxiety. Policies that expand 
insurance coverage to high-risk groups have the potential to improve treatment rates.  
The Affordable Care Act (ACA) included a provision aimed at improving insurance 
coverage for young adults. Young adulthood is a period not only associated with high rates 
of uninsurance, but also a time when depression and anxiety tend to emerge [11, 61]. The 
ACA’s dependent coverage provision (DCP), implemented in September 2010, required 
insurers to extend coverage up to age 26 on any parental plan offering dependent coverage. 
Furthermore, the DCP applied regardless of student status, marital status, residency outside 
the parent’s home, or having children—conditions which were previously used to restrict 
dependent coverage [6, 14]. Early evidence demonstrated that many young adults gained 
private coverage through this mechanism, including one analysis indicating that individuals 
with worse self-reported health experienced larger coverage gains initially [16, 21, 62-66].  
Early studies also showed improvements in access to care associated with the policy 
[15-21]. Some research detected general increases in the likelihood of receiving any mental 
health treatment as a result of the policy [23]. Other research detected specific increases in 
the probability of using hospital-based services, including inpatient treatment for mental 
health problems such as depression and psychosis [15, 19]; however, results were mixed for 
emergency settings [19, 22]. Research examining changes in the intensity of mental health 
care found no changes in the length of stay or number of procedures performed in inpatient 
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settings as a result of the policy, but consistently found increases in the share of expenditures 
covered by private insurers [15, 19, 22]. Increases in hospital-based services could reflect 
increased access to inpatient care directly or indirectly through increased access to outpatient 
services that identify individuals who could benefit from inpatient treatment [19]. To date, 
patterns of mental health service use and spending have not been examined in relation to 
outpatient mental health care. The purpose of this study was to examine the effect of the 
DCP on mental health service use and spending across treatment settings within the 
privately insured young adult population.  
Studying the DCP in this group has additional implications since the coverage 
mandate may have drawn individuals who have greater mental health treatment needs to 
private insurance plans [67]. Eventually, the DCP could help ensure uninterrupted coverage 
during a period when risk of uninsurance is high; however, its implementation initially 
presented a new coverage option for young adults without insurance. As a result, a larger 
proportion of the privately insured young adult population was newly covered following 
implementation [66]. Changes in service utilization after implementation could arise through 
two mechanisms. First, newly insured young adults could have unmet need for mental health 
treatment since uninsured individuals are both more likely to need mental health care and 
less likely to receive care than covered individuals [68]. Second, adverse selection could have 
led those with mental health treatment needs or more serious or chronic mental health 
problems to take advantage of the DCP disproportionately to healthy young adults. This 
study explored both of these possibilities. 
In addition to examining the effect of the DCP on inpatient and outpatient mental 
health service use and total and out-of-pocket spending among privately insured young 
adults with depression and anxiety diagnoses, an analysis of only new enrollees aimed to 
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understand changes within the pool of covered young adults, including whether selection 
into plans changed after the DCP. Among the full group of young adults ages 19 to 25 with 
depression and anxiety diagnoses, it was hypothesized that the DCP led to increases in: 1) 
the probability of using inpatient and outpatient mental health services, 2) the quantity of 
outpatient mental health services used, and 3) total and out-of-pocket spending on mental 
health care. If increases in mental health service use and spending were related to gaining 
access to insurance, young adults who newly enrolled in insurance after the DCP was 
implemented might have similar utilization to new enrollees before the policy; however, if 
increases in mental health service use and spending were related to adverse selection into 
plans by individuals with mental health treatment needs or greater levels of need, young 
adults who newly enrolled in insurance after the DCP was implemented might have higher 
utilization than new enrollees before the policy. Among the newly enrolled group of young 
adults ages 19-25 with depression and anxiety diagnoses, it was hypothesized that the DCP 
led to increases in all utilization and spending outcomes.  
Methods   
Data 
Data were drawn from the Truven Health MarketScan® Commercial Claims and 
Encounters database, which includes inpatient, outpatient, and pharmaceutical claims for 
individuals insured by large, employer-sponsored plans. These data are longitudinal at the 
individual level, allowing service utilization and costs to be calculated for each enrollee over 
time. The pre-policy period included data from 2007-2009, and the post-policy period 
included data from 2011-2012. Data from 2010 were excluded because it was largely a 
transition year in which some insurers implemented dependent coverage requirements early 
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and others implemented in September with changes effective at the start of the 2011 plan 
year [69].  
Sample 
The treatment group included young adults 19-25 years old who were targeted by the 
policy. Because the policy was national in scope, the comparison group included older young 
adults 27-33 years old who were likely to have similar health care needs but were not eligible 
for dependent coverage under the ACA due to their age. Similar to prior research, 
individuals who were 26 years old were excluded from analyses because they might have 
been covered under the provision during part of the year in which they turned 26, 
complicating their group assignment for the calendar year [15]. All enrollees meeting criteria 
for age and continuous calendar year enrollment were included in analyses of the probability 
of service use.  
Analyses of the quantity of service use and mental health spending were limited to 
young adults with depression and anxiety diagnoses, defined by the presence of at least one 
inpatient or outpatient claim with a relevant diagnosis in the calendar year in which they met 
criteria for age and continuous enrollment described above. International Classification of 
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes used to categorize 
depression diagnoses were 296.2, 296.3, 300.4, and 311 and anxiety diagnoses were 300.0, 
300.2, 300.3, 309.81, and 313.0-313.2 [70]. 
Outcome Measures 
 Using depression and anxiety diagnoses in addition to relevant procedure codes, 
inpatient and outpatient services were categorized to examine outcomes related to 
probability of service, intensity of service use, and spending. Similar to other established 
approaches, inpatient services were categorized as depression or anxiety-related 
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hospitalizations if at least half of all inpatient claims associated with the hospitalization had a 
relevant diagnosis and the last (discharge) claim also had a relevant diagnosis [36, 71]. 
Outpatient services were categorized according to a relevant diagnosis or procedure code on 
the outpatient claim. Depression and anxiety services included outpatient claims with either a 
depression or anxiety diagnosis. Psychotherapy and medication management services 
included outpatient claims with either a Current Procedural Terminology (CPT) or 
Healthcare Common Procedure Coding System (HCPCS) code for psychotherapy or 
medication management, respectively.  
The probabilities of using inpatient depression or anxiety services, outpatient 
depression or anxiety services, outpatient psychotherapy, and outpatient medication 
management in a given year were calculated among individuals who met criteria for age and 
continuous calendar year enrollment. Intensity of service use was calculated among 
individuals with depression and anxiety diagnoses who met criteria for age and continuous 
calendar year enrollment as the average total number of outpatient depression or anxiety 
services, psychotherapy services, and medication management services per person per year, 
conditional on using the service.  
Total and out-of-pocket spending were measured among individuals with depression 
and anxiety diagnoses. Total and out-of-pocket spending were calculated as the average 
number of U.S. dollars per person per year spent on inpatient, outpatient, and prescription 
drug services adjusted for inflation to 2012 dollars using the Consumer Price Index. Total 
spending included the total amount eligible for payment to a provider before out-of-pocket 





 For each outcome, a difference-in-differences study design was used to measure the 
effect of implementing the DCP by comparing the change over time between the periods 
after and before implementation in the average value of the outcomes for the young adult 
treatment group compared to older young adults. Older young adult adults serve as a 
comparison group for outcomes expected in the absence of the DCP because older young 
adults were not impacted by the policy but experienced similar economic conditions. To 
obtain the difference-in-differences estimate, regression models included an interaction term 
for policy period (pre-DCP and post-DCP) and study group (treatment and comparison). In 
addition to the difference-in-differences interaction, all models included individual terms for 
the policy period and study group and covariates to adjust for age, sex, census region, and 
urban/rural setting.   
Using Stata statistical software, logistic regressions estimated effects of the DCP on 
the probability of using any inpatient or outpatient depression or anxiety services and 
specific outpatient psychotherapy and medication management services [72]. Because service 
use intensity represents a count, negative binomial regressions estimated the effects of the 
DCP on the average annual number of outpatient services per person among individuals 
with depression or anxiety diagnoses who used each service. The effects of the DCP on 
average total and out-of-pocket spending per person were estimated separately with two-part 
models, first using logistic regression to estimate any non-zero spending and then using 
generalized linear models (GLMs) with a log transformation and a gamma distribution. 
Model fit was assessed using alternative linear model specifications, including ordinary least 
squares (OLS) regression. Spending predictions were robust to model specifications, 
including GLM and OLS models applied to raw and log-transformed data in addition to 
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GLM models assuming various distributions. Standard errors for all models were clustered at 
the enrollee level.  
Insurance status and mental health care utilization and spending prior to enrollment 
in private insurance were not observable in these data. To assess whether utilization 
increases among young adults who benefitted from the policy were indicative of selection 
into insurance plans, a subgroup of enrollees in only the first calendar year they met age and 
enrollment criteria was analyzed separately. Increases in the probability of using mental 
health services could signal treatment for previously unmet needs, while higher intensity 
utilization of mental health services could indicate greater treatment needs among newly 
enrolled young adults. The new enrollee sample was identified using the same age and 
continuous enrollment criteria as the primary analysis. 
 The difference-in-difference method assumes differences between the treatment and 
comparison groups’ mental health service use and spending in the pre-policy period would 
persist into the post-policy period in the absence of the DCP. Other research has specifically 
challenged this assumption in studies of the DCP that compare young adults to older young 
adults, expressing concerns that these age groups experience different economic forces [73]. 
One solution used in prior research examines outcomes using more narrowly defined age 
groups that are more likely to respond similarly to shifts in labor and health insurance 
markets [15, 63]. To provide confidence in the results for the full range of young adults who 
could have been affected by the DCP, a sensitivity analysis applied this more conservative 
approach by comparing young adults 23-25 years old with older young adults 27-29 years 
old. Focusing on narrower age ranges also excluded many college-age adults whose potential 
to have dependent coverage based on their student status could diminish measured effects of 
the DCP [14]. Studying the private insurance population allowed for an additional sensitivity 
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analysis to compare outcomes for 19-25 year olds enrolled as dependent children with 19-25 
year olds enrolled as primary beneficiaries. Sensitivity analyses were conducted for both the 
primary (see Appendix A) and new enrollee analyses (see Appendix B).  
Results 
In the pre-policy period (2007-2009), young adults 19-25 years old with depression 
and anxiety diagnoses (N=119,998) were continuously enrolled with a relevant diagnosis for 
a total of 142,196 person-years and adults 27-33 years old with depression and anxiety 
diagnoses (N=185,264) were continuously enrolled with a relevant diagnosis for a total of 
231,801 person-years. In the post-policy period (2011-2012), young adults 19-25 years old 
with depression and anxiety diagnoses (N=168,880) were continuously enrolled with a 
relevant diagnosis for a total of 198,768 person-years and adults 27-33 years old with 
depression and anxiety diagnoses (N=171,632) were continuously enrolled with a relevant 
diagnosis for a total of 202,512 person-years. A larger proportion of young adults 19-25 
years old with depression and anxiety diagnoses were child dependents in the post-policy 
period (N=128,584, 76.1%) than in the pre-policy period (N=66,465, 55.4%). A small 
minority of adults 27-33 years old with depression and anxiety diagnoses were child 
dependents in both the post-policy period (N=1,063, 0.6%) the pre-policy period (N=1,285, 
0.7%) 
Baseline demographic and clinical characteristics of enrollees with depression and 
anxiety diagnoses in the period before the DCP was implemented are shown in Table 2.1. 
For each study group in the pre-policy period, baseline demographic and clinical 
characteristics are averages of the first year an individual had a depression or anxiety 
diagnosis, met age criteria, and were continuously enrolled (Table 2.1). At baseline, both the 
young adult group (67.3%) and the comparison group (69.3%) were mostly female. Few 
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enrollees in the young adult group used inpatient depression or anxiety services (2.7%), while 
most used outpatient depression or anxiety services (99.3%). Less than half of young adults 
used psychotherapy (42.8%) and a minority used medication management services (5.8%). 
Similarly, few enrollees in the comparison group used inpatient depression or anxiety 
services (1.9%), while most used outpatient depression or anxiety services (99.6%). Less than 
half of enrollees in the comparison group used psychotherapy (43.3%) and a minority used 
medication management services (6.1%). On average, the young adult group had somewhat 
lower intensity outpatient service use at baseline for depression or anxiety, psychotherapy, 
and medication management than the comparison group. 
Estimated effects of the policy on service use and spending outcomes are shown in 
Table 2.2. Compared to adults 27-33 years old, young adults 19-25 years old were 
significantly more likely to use both inpatient (p<0.001) and outpatient (p<0.001) depression 
or anxiety services, psychotherapy (p<0.001), and medication management (p<0.001) after 
the DCP was implemented. These changes in the probability of service use represented 
increases above young adults’ pre-policy rates of service use ranging from 9.2% for 
outpatient depression or anxiety services to 33.3% for inpatient depression or anxiety-related 
hospitalizations. Among individuals with depression and anxiety diagnoses, young adults had 
significant increases in the quantity of outpatient depression or anxiety services (p<0.001) 
and psychotherapy (p<0.001), but no difference in medication management (p=0.750) 
compared to adults 27-33 years old. Increases in the quantity of outpatient depression or 
anxiety services and psychotherapy associated with policy implementation were small, each 
averaging less than one additional visit per person per year. Among individuals with 
depression or anxiety diagnoses, young adults 19-25 years old had significant increases in 
total spending (p<0.001) and out-of-pocket spending (p<0.001) compared to adults 27-33 
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years old. Increases in spending associated with the DCP averaged $661 total and $80 out-
of-pocket per person per year. 
Sensitivity analyses comparing young adults 23-25 years old with adults 27-29 years 
old produced similar statistically significant results as the full group findings, but increases in 
the probability of service use were higher while increases in the quantity of services used and 
spending increases were lower in magnitude. Sensitivity analyses comparing young adults 19-
25 years old enrolled as dependents to those enrolled as the primary beneficiary 
demonstrated higher increases in the probability of using inpatient and outpatient depression 
or anxiety services overall, but no differences either in the probability of using specific 
outpatient services or in the quantity of services used; spending increases were lower in 
magnitude than the full and narrow group findings (see Appendix A).  
New Enrollees 
Demographic and clinical characteristics of new enrollees with depression or anxiety 
in the period before DCP implementation were similar to baseline characteristics of all 
enrollees on average (Table 2.1). Difference-in-difference estimates for new enrollees are 
shown in Table 2.2. After the DCP was implemented, newly enrolled young adults 19-25 
years old had significantly greater increases in the probability of using all inpatient and 
outpatient services compared to newly enrolled adults 27-33 years old (p<0.001 for all 
services measured). Newly enrolled young adults 19-25 years old used significantly more 
depression or anxiety outpatient services compared to older young adults 27-33 years old 
(p<0.001), but there were no differences between groups in the number of psychotherapy 
(p=0.403) or medication management services used (p=0.613). The DCP was associated 
with greater increases in total (p<0.001) and out-of-pocket spending (p<0.001) for newly 
enrolled young adults 19-25 years old compared to newly enrolled adults 27-33 years old.  
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Sensitivity analyses comparing narrower age ranges of newly enrolled young adults 
produced similar statistically significant increases in probability of service use and spending; 
however, there were no differences detected in the quantity of services used. Sensitivity 
analyses comparing newly enrolled young adult dependents with primary beneficiaries 
demonstrated higher magnitude increases in the probability of using inpatient and outpatient 
depression or anxiety services, but no differences in the number of outpatient services used. 
Increases in spending were similar to the full sample of new enrollees (see Appendix B). 
Difference-in-difference estimates from the primary analysis and new enrollee analysis, 
including sensitivity groups, are presented in Table 2.3.  
Discussion 
 This study found that the DCP was associated with increases in mental health service 
use and spending among privately insured young adults with depression and anxiety 
diagnoses. Increases in the probability of using inpatient and outpatient services were 
consistent with previous research, which has found higher inpatient utilization for mental-
health related problems and evidence suggestive of increases in outpatient mental health 
treatment attributable to the DCP [15, 19, 23]. In addition to higher rates of outpatient 
service use, some findings suggest that young adults had increased service use intensity as a 
result of the DCP. Generally, more intensive outpatient treatment could be explained by 
greater emphasis on ambulatory mental health care, which can reduce the need for hospital-
based care if mental illness is identified and treated in outpatient settings [19, 74, 75]. After 
the DCP was implemented, higher intensity outpatient use also could have occurred if young 
adults who gained new coverage as a result of the policy had greater treatment needs due to 
more chronic or serious mental health problems.  
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Results from the new enrollee analyses showed more young adults accessed services 
but largely suggest they did not use more services per person as a result of the policy. These 
findings suggest that young adults who gained new insurance coverage following 
implementation of the DCP had higher rates of mental health service use, but treatment 
levels that were comparable to young adults who were being treated for depression and 
anxiety prior to implementation of the DCP. Studies in inpatient settings have also found 
that the DCP was associated with increased probability of care but not more intensive care, 
indicating young adults used inpatient services at higher rates but had similar levels of 
treatment as other inpatients [15]. Other research has shown that significant increases in 
mental health treatment as a result of the DCP were concentrated among young adults with 
possible behavioral health treatment needs, but whether increases reflected treatment for a 
mild or transient condition or treatment for more chronic or severe conditions is unknown 
[23]. Previous research is compatible with the findings presented here, but this work is the 
first to address changes in mental health care among the privately insured young adult 
population that could potentially reflect adverse selection as a result of the DCP. The results 
are not conclusive since previous coverage and service use remain unknown, but they 
provide an important perspective on changes in treatment within the insurance pool covered 
by large employers.  
Rates of mental health service use increased significantly after the DCP was 
implemented. Estimates for the probability of service use ranged from 9% to 29% increases 
over rates in the pre-policy period among the full group of young adults and from 11% to 
33% over pre-policy utilization rates among new enrollees, suggesting the DCP potentially 
led to higher utilization rates unrelated to newly enrolling in coverage. Although some 
mental health service use outcomes measuring the quantity of services used increased 
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significantly after the DCP was implemented, estimates were relatively small. The largest 
estimated increase in the quantity of outpatient services used was an increase of less than one 
additional depression or anxiety visit per year for each user of outpatient depression or 
anxiety services among the full group of young adults. Other increases in the intensity of 
outpatient service use were smaller or not significant.  
Consistent with increases in service use, the DCP was associated with higher average 
total and out-of-pocket spending. Estimates ranged from $494 to $678 in total spending and 
from $51 to $80 in out-of-pocket spending on average per person per year. Although the 
spending increases assumed by employer-sponsored insurers is not insignificant within the 
subset of privately insured young adults with depression or anxiety, increases would be much 
smaller when aggregated across all enrollees. The magnitude of out-of-pocket spending 
increases cannot be determined without information related to previous insurance coverage 
and service use. Modest increases could be difficult for some young adults to assume, but 
estimates for out-of-pocket spending increases represent a fraction of the cost of care 
without insurance. 
The data were drawn from private employer-sponsored insurance plans, which offers 
an important perspective given that over half of the U.S. population was covered by 
employer-sponsored insurance in 2012 [76]; however, the main limitation of analyzing 
private insurance claims is the inability to explain increased rates of mental health service use 
and spending in relation to prior coverage and utilization. Another limitation of the 
insurance claims studied here is that the information comes from only large employers. 
While the dataset includes around 20 million covered lives each year, the results are not 
necessarily representative of all individuals covered by large group insurance. Furthermore, 
the results are not generalizable to the smaller subset of individuals with private insurance 
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obtained through the individual market or small employers [77, 78]. Due to their smaller 
enrollee pools, individual and small group plans may be more affected by changes in 
utilization and spending that result from adverse selection.  
Another challenge of insurance claims is the limited demographic information 
available, which restricts the ability to assess the comparability of treatment and comparison 
groups. To address the primary concerns that have been raised in relation to the 
appropriateness of study groups, multiple sensitivity analyses were conducted that produced 
similar statistically significant results and provided confidence in the overall findings of the 
study. Nonetheless, some potentially important characteristics that could be associated with 
variation in mental health care utilization were not observed and could not be controlled for 
in the analyses, such as race/ethnicity and socioeconomic status.  
Conclusion 
Findings indicate the DCP led to increased rates of mental health service use among 
young adults with depression and anxiety diagnoses in the first two years after full 
implementation, suggesting the DCP increased access to care for a high-risk population of 
young adults. Increased utilization rates could be explained by coverage of previously 
uninsured individuals, which may have a higher proportion of young adults with need for 
mental health treatment. Alternatively, increased utilization could result from coverage of a 
disproportionate share of young adults with need for mental health treatment, which may 
indicate adverse selection into plans. In either case, young adults who gained coverage after 
the DCP was implemented had similar levels of utilization as young adults who newly 
enrolled in insurance before implementation, which suggests the mental health problems of 
new enrollees were not more severe or chronic. With increased access to care, modest 
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spending increases were observed; however, higher mental health service use and spending 
attributable to the DCP may be unique to this early post-policy period.  
Over time, the DCP should act primarily as a means of continuous rather than new 
coverage, reducing the proportion of young adults that access mental health care because of 
unmet treatment needs. To date, published studies have assessed the impact of the DCP on 
mental health care utilization and spending using data from 2012 or earlier. Another ACA 
provision known as the individual mandate was implemented in 2014, requiring nearly all 
U.S. citizens to have health insurance or pay a fee when filing taxes [79]. Because the penalty 
for uninsurance was introduced incrementally, measures of mental health care utilization and 
spending may be more balanced in later years. In other words, as insurance coverage became 
more affordable than uninsurance, healthy young adults might be represented more 
proportionately in private insurance [12].
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Table 2.1 Baseline characteristics of young adults with depression and anxiety diagnoses before the DCP was implemented, stratified by 
primary and new enrollee analyses 
 Primary Analysis New Enrollee Analysis 
 19-25 years old 27-33 years old 19-25 years old 27-33 years old 
 N % N % N % N % 
 119,998   185,264  91,091  122,778  
Sex         
Female 80,769 67.3 128,351 69.3 61,712 67.7 85,416 69.6 
Census Region         
Northeast 18,675 15.6 28,551 15.4 14,775 16.2 20,204 16.5 
Midwest 32,331 26.9 45,875 24.8 24,364 26.7 30,163 24.6 
South 40,134 33.4 70,864 38.3 30,432 33.4 46,163 37.6 
West 28,858 24.0 39,974 21.6 21,520 23.6 26,248 21.4 
Urban/rural         
MSA 106,092 88.4 163,512 88.3 80,795 88.7 109,160 88.9 
Diagnoses         
Depression alone 55,491 46.2 87,323 47.1 42,910 47.1 59,235 48.2 
Anxiety alone 48,356 40.3 73,871 39.9 35,505 39.0 46,874 38.2 
Depression and anxiety 16,151 13.5 24,070 13.0 12,676 13.9 16,669 13.6 
Comorbidities         
Any mental illness 28,252 23.5 36,955 19.9 21,650 23.8 24,582 20.0 
   Bipolar disorder 6,852 5.7 7,963 4.3 5,584 6.1 5,781 4.7 
   Substance use disorder 6,834 5.7 6,169 3.3 5,238 5.8 4,203 3.4 
Service use         
Any inpatient depression or anxiety service use 3,283 2.7 3,576 1.9 2,214 2.4 1,968 1.6 
Any outpatient depression or anxiety service use 119,208 99.3 184,483 99.6 90,504 99.4 122,279 99.6 
Average depression or anxiety services per year among users 5.83   6.14   6.14   6.64   
Any outpatient psychotherapy service use 51,394 42.8 80,209 43.3 40,783 44.8 56,413 45.9 
Average psychotherapy services per year among users 8.92   9.69   9.24   10.25   
Any outpatient medication management service use 18,122 5.8 23,838 6.1 15,270 5.8 18,217 6.1 
Average medication management services per year among users 3.36   3.48   3.41   3.55   




Table 2.2 Estimated effects of the DCP on mental health service use and spending among young adults with depression and anxiety 
diagnoses 
Primary Analysis 
19-25 years old 27-33 years old 
 
Pre-DCP Post-DCP Pre-DCP Post-DCP 
Probability of service use %b 95% CI % 95% CI % 95% CI % 95% CI DDa 95% CI p 
Inpatient or Outpatient Depression or Anxiety 6.54 6.48-6.59 8.20 8.15-8.26 7.10 7.06-7.14 8.16 8.10-8.22 0.60 0.53-0.67 <0.001 
Inpatient Depression or Anxiety 0.12 0.12-0.13 0.21 0.20-0.22 0.14 0.14-0.15 0.19 0.18-0.20 0.04 0.02-0.05 <0.001 
Outpatient Depression or Anxiety 6.52 6.46-6.57 8.17 8.11-6.57 7.07 7.03-7.12 8.13 8.07-8.19 0.60 0.52-0.67 <0.001 
Psychotherapy 2.89 2.85-2.93 3.64 3.60-3.68 3.31 3.28-3.34 3.59 3.54-3.63 0.47 0.42-0.52 <0.001 
Medication management 1.02 1.00-1.04 1.18 1.16-1.20 1.11 1.09-1.13 1.11 1.09-1.14 0.16 0.13-0.19 <0.001 
Intensity of outpatient service use among 
users N
c 95% CI N 95% CI N 95% CI N 95% CI DD 95% CI p 
Depression or anxiety 6.54 6.45-6.62 7.50 7.42-7.59 6.47 6.42-6.53 6.90 6.83-6.98 0.53 0.43-0.64 <0.001 
Psychotherapy 10.25 10.08-10.41 11.24 11.09-11.40 9.83 9.73-9.93 10.31 10.18-10.45 0.51 0.32-0.70 <0.001 
Medication management 3.63 3.56-3.70 3.58 3.52-3.64 3.48 3.43-3.53 3.42 3.36-3.48 0.01 -0.07-0.09 0.770 
Mental Health Spending $d 95% CI $ 95% CI $ 95% CI $ 95% CI DD 95% CI p 
Total 2,065 2,014-2,115 2,817 2,756-2,878 1,877 1,848-1,907 1,969 1,928-2,010 661 595-727 <0.001 
Out-of-pocket 358 352-364 456 449-452 360 355-364 378 372-383 80 72-87 <0.001 
New Enrollee Analysis 
19-25 years old 27-33 years old 
 
Pre-DCP Post-DCP Pre-DCP Post-DCP 
Probability of service use %b 95% CI % 95% CI % 95% CI % 95% CI DDa 95% CI p 
Inpatient or Outpatient Depression or Anxiety 6.19 6.13-6.24 7.79 7.73-7.86 7.02 6.96-7.07 7.97 7.88-8.06 0.65 0.55-0.75 <0.001 
Inpatient Depression or Anxiety 0.12 0.11-0.12 0.22 0.21-0.23 0.15 0.14-0.16 0.21 0.19-0.23 0.04 0.02-0.06 <0.001 
Outpatient Depression or Anxiety 6.17 6.11-6.23 7.76 7.69-7.82 6.99 6.94-7.05 7.93 7.84-8.02 0.65 0.55-0.75 <0.001 
Psychotherapy 2.63 2.59-2.66 3.19 3.15-3.23 3.39 3.35-3.43 3.49 3.43-3.55 0.46 0.39-0.53 <0.001 
Medication management 0.92 0.90-0.94 1.03 1.01-1.06 1.17 1.14-1.19 1.11 1.07-1.15 0.17 0.13-0.21 <0.001 
Intensity of outpatient service use among 
users N
c 95% CI N 95% CI N 95% CI N 95% CI DD 95% CI p 
Depression or anxiety 6.26 6.16-6.35 7.08 6.98-7.18 6.53 6.45-6.60 7.03 6.91-7.15 0.31 0.17-0.46 <0.001 
Psychotherapy 9.86 9.68-10.05 10.45 10.26-10.63 9.80 9.67-9.93 10.27 10.06-10.49 0.11 -0.14-0.37 0.403 
Medication management 3.47 3.39-3.55 3.36 3.28-3.44 3.50 3.43-3.56 3.35 3.26-3.45 0.03 -0.09-0.15 0.613 
Mental Health Spending $d 95% CI $ 95% CI $ 95% CI $ 95% CI DD 95% CI p 
Total 1,868 1,820-1,916 2,597 2,527-2,667 1,963 1,919-2,008 2,157 2,085-2,230 535 445-625 <0.001 
Out-of-pocket 351 344-358 461 453-470 371 365-377 422 412-431 60 48-72 <0.001 
a Difference-in-differences are regression-adjusted predictions of the interaction between age group and policy period 
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b Values are regression-adjusted predictions of percentage who used services 
c Values are regression-adjusted predictions of average services used per person per year among individuals who used services 
d Values are regression-adjusted predictions of average dollars per person per year 
Note: All regressions adjust for sex, age, census region, MSA, age group, year, and policy period 
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Table 2.3 Estimated effects of the DCP on mental health service use and spending among young adults with depression and anxiety 
diagnoses, stratified by analysis 
 Primary Analysis New Enrollee Analysis 
















Primary 27-33 27-29 
19-25 
Primary 
Probability Outcomes (% using at least 1 service per year)       
Any inpatient or outpatient depression or anxiety service 0.60*** 0.80*** 0.89*** 0.65*** 0.70*** 1.32*** 
Any inpatient depression or anxiety service 0.04*** 0.04*** 0.09*** 0.04*** 0.03*** 0.12*** 
Any outpatient depression or anxiety service 0.60*** 0.80*** 0.88*** 0.65*** 0.70*** 1.30*** 
Any outpatient psychotherapy service 0.47*** 0.64*** 0.24 0.46*** 0.40*** 0.35*** 
Any outpatient medication management service 0.16*** 0.26*** 0.03 0.17*** 0.15*** 0.06*** 
Outpatient Intensity Outcomes (N services per person per year)       
Number of depression or anxiety services, among users 0.53*** 0.45*** 0.10 0.31*** -0.01 0.08 
Number of psychotherapy services, among users 0.51*** 0.39* 0.04 0.11 -0.37 -0.25 
Number of medication management services, among users 0.01 0.02 0.03 0.03 0.02 0.02 
Spending Outcomes (USD per person per year)       
Total Spending 661*** 678*** 494*** 535*** 506*** 509*** 




a Estimates are regression-adjusted difference-in-difference predictions from Table 2.2 
b Estimates are regression-adjusted difference-in-difference predictions from Supplemental Table A-2 
c Estimates are regression-adjusted difference-in-difference predictions from Supplemental Table B-2 
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Objective: The purpose of this study was to examine the impact of the 2008 Mental Health 
Parity and Addiction Equity Act (MHPAEA) on mental health service use and spending 
among young adults with depression and anxiety diagnoses who have private health 
insurance coverage.  
Methods: Data were large employer-sponsored insurance claims from the MarketScan 
database. Interrupted time series models were used to estimate changes in the probability of 
using mental health services, the quantity of services used, and average spending among 
younger adults 26-33 years old across two time points: the pre-policy period (2007-2009) and 
the post-policy period (2010-2012). Outcomes included depression and anxiety-related 
inpatient and outpatient services, outpatient psychotherapy and medication management, 
and total and out-of-pocket mental health spending.  
Results: Implementation of the parity law was associated with an increase in the probability 
of using inpatient depression or anxiety services at the time of policy implementation, but a 
decrease in inpatient use over time. The probability of outpatient psychotherapy decreased 
initially, and the probability of medication management increased over time after the policy 
was implemented. The cumulative effect at one year post-implementation was a 0.2% 
increased probability of using inpatient services, a 7.8% decreased probability of using 
psychotherapy, and a 1.3% increased probability of using medication management. The 
number of medication management services used per month increased slightly as a result of 
the parity law, but the cumulative effect at one year post-implementation was 0.2 additional 
visits per user. Trends in total spending decreased slightly after implementation, while out-
of-pocket spending remained steady. 
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Conclusions: Changes in service use highlight potential heterogeneity in the association 
between the parity law and specific services. Among young adults with depression and 
anxiety diagnoses, the parity law was not associated either with higher total spending as some 
predicted or with increased financial protection as supporters anticipated and research on 
other mental illnesses has found.  
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Introduction 
The Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 responded 
to limitations previously placed on mental health coverage in the private insurance market. 
The federal parity law required group insurers with 50 or more enrollees who offer mental 
health and addiction benefits to provide those benefits with equal financial requirements and 
treatment limitations as medical and surgical benefits. Prior research evaluating the effects of 
parity regulations implemented at the state level and by the Federal Employees’ Health 
Benefits Program showed that parity regulations could lead to more equitable coverage 
without substantially driving up health care expenditures, which was instrumental in passage 
of the MHPAEA [80].  
Research suggests the parity law was associated with more generous mental health 
benefits [30, 31, 34]. Cost sharing requirements decreased among insurance plans that did 
not meet parity prior to the law’s implementation [30]. Commercial insurers removed many 
treatment limitations, such as annual caps on services [31]. Changes in cost sharing and other 
quantitative limitations could reduce barriers to care, and some evidence has linked the 
elimination of treatment caps to increases in mental health service use among individuals 
with high intensity mental health care utilization [34]. In addition to increases in access to 
services, recent studies have also found improvements in financial protection against the cost 
of treatment [35-37]. 
A broad investigation of the associations between the federal parity law and 
behavioral health service use from 2008-2013 found increases in outpatient utilization and 
total spending, but no significant changes in out-of-pocket spending among enrollees 
covered by insurance plans with integrated behavioral health benefits; however, the service 
use and spending increases were small [35]. For example, trends in psychotherapy services 
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increased by 0.00017 visits per member per month and trends in total spending increased by 
88 cents per member per month over the period after implementation [35]. Evidence related 
to specific behavioral health conditions has demonstrated similar findings.  
One study showed that the parity law led to increases in mental health service use 
and total spending for children with autism spectrum disorder without significant changes in 
out-of-pocket spending [36]. After the parity law was implemented, trends in outpatient 
mental health and functional therapy service use increased by 0.0015 visits per child per 
month and trends in total spending increased by 2 dollars per child per month [36]. Another 
study examined out-of-network treatment for substance use disorders and found increases in 
service use and total spending attributable to the parity law, but no significant changes in 
out-of-pocket spending [37]. Over the period after implementation, trends in inpatient and 
outpatient service use increased by 0.0024 hospitalizations and 0.0016 visits per person per 
month, respectively [37]. Trends in total spending increased by approximately $50 for 
inpatient services and $25 for outpatient services per person per month after the MHPAEA 
was implemented [37].  
The substantially higher spending estimates for substance abuse treatment in relation 
to spending results from other studies could reflect the nature of out-of-network care, which 
tends to be more expensive since insurers do not negotiate service costs with non-
participating providers. Additionally, the greater service use increases for both autism 
spectrum disorders and substance use disorders relative to overall behavioral health care may 
reflect how the study samples were defined. The studies examining specific disorders 
analyzed service use among individuals with a diagnosis, while the study of behavioral health 
care analyzed service use among the entire enrolled population. Including enrollees without a 
behavioral health diagnosis results in lower utilization rates for behavioral health services, 
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corresponding to smaller magnitude estimates of the changes associated with implementing 
the federal parity law.     
Research to date has described changes in access to care and financial protection for 
individuals with substance use disorders and developmental disorders, but the association 
between the parity law and changes in mental health service use and spending has not been 
investigated for other specific disorders. In particular, no studies have focused on depression 
and anxiety disorders, which are the most prevalent mental illnesses in the U.S. [1]. The 
recent study of all behavioral health care provides some insight into changes in utilization 
and spending for these common mental illnesses since over half of those who used 
behavioral health services had either a depression or anxiety diagnosis [35]. The results 
indicated that increases in behavioral health care utilization attributable to the parity law were 
concentrated among outpatient services, which could be explained in part by treatment for 
common mental illness that often occurs in ambulatory settings [35].  
Adolescence and early adulthood are a critical period for treating depression and 
anxiety, both of which tend to emerge during these developmental stages [11]. In fact, most 
of the burden of disease for depression and anxiety occurs from 15-34 years of age [7]. In 
addition to being a high-risk period for common mental illnesses, young adulthood is 
associated with insurance problems such as underinsurance, which describes those with 
coverage for whom cost remains a barrier to treatment [12]. Most young adults 19-29 years 
old with health insurance are covered by an employer-sponsored plan through their own 
employers, but some are covered as dependents through a parent’s employer plan [81]. In 
2009, older young adults 24-29 years old were more than twice as likely to be covered 
through their own employers than those 19-23 years old [81]. Recognizing the insurance 
problems associated with young adulthood, comprehensive health reform achieved through 
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the 2010 passage of the Affordable Care Act (ACA) targeted young adults with a provision 
that expanded access to potentially more generous dependent coverage for 19-25 year olds; 
however, older young adults were ineligible for coverage under the provision. Therefore, 
older young adults continue to rely on their own employer-sponsored private insurance as 
before the ACA, and more so in relation to their younger counterparts [81].  
The present study focused on young adults because they are at risk of both common 
mental illnesses and insurance problems. The objective was to examine the relationship 
between the federal parity law and mental health service use and spending among older 
young adults 26-33 years old with depression and anxiety diagnoses, excluding young adults 
19-25 years old whose service use could be affected by the ACA around the time the parity 
law was implemented. Among older young adults diagnosed with depression and anxiety, it 
was hypothesized that the parity law led to increases in: 1) the probability of inpatient and 
outpatient mental health service use, 2) the quantity of outpatient mental health services used 
and 3) total spending on mental health care, but no changes in out-of-pocket spending. The 
findings have implications for planning future initiatives that aim to improve access to 
mental health services for older young adults at higher risk of experiencing problems with 
mental health and insurance coverage while managing spending.  
Methods 
Data 
Data were obtained from the Truven Health MarketScan® Commercial Claims and 
Encounters database, which includes inpatient, outpatient, and pharmaceutical claims for 
individuals insured by large employer-sponsored plans. The data are longitudinal at the 
individual level, allowing service utilization and costs to be calculated for each enrollee over 
time. The pre-parity period included data from 2007-2009, and the post-parity period 
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included data from 2010-2012, capturing the three plan years both before and after the parity 
law was implemented in January 2010.  
Sample 
Adults 26-33 years old were included in the sample for each calendar year in which 
they were continuously enrolled. Adults 19-25 years old were excluded because service use 
and spending by this group was likely to have been impacted by the ACA. Continuous 
enrollment across the entire study period was not required because many young adults are 
susceptible to experiencing gaps in insurance coverage, especially if they have low to 
moderate income levels [12]. Requiring calendar year enrollment ensured averages could be 
calculated in all months of the year for each person without biasing the sample toward those 
with potentially more stable employment and higher incomes who could experience fewer 
cost-related barriers to care. Individuals were identified with depression and anxiety 
diagnoses if at least one inpatient or outpatient claim had a relevant diagnosis in the calendar 
year in which they met age and continuous enrollment criteria described above. The 
International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) 
diagnostic codes used to categorize these conditions were 296.2, 296.3, 300.4, and 311 for 
depression and 300.0, 300.2, 300.3, 309.81, and 313.0-313.2 for anxiety disorders [70]. 
Outcome Measures 
 Depression and anxiety diagnoses in addition to relevant procedure codes were used 
to categorize inpatient and outpatient services in order to examine outcomes for the 
probability and quantity of service use. Similar to other established approaches, inpatient 
services were categorized as depression or anxiety-related hospitalizations if at least half of 
all inpatient claims associated with the hospitalization had a relevant diagnosis and the last 
(discharge) claim also had a relevant diagnosis [36, 71]. Outpatient services were categorized 
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according to a relevant diagnosis or procedure code on the outpatient claim. Depression and 
anxiety services included outpatient claims with either a depression or anxiety diagnosis. 
Psychotherapy and medication management services included outpatient claims with either a 
Current Procedural Terminology (CPT) or Healthcare Common Procedure Coding System 
(HCPCS) code for psychotherapy or medication management, respectively.  
Probability of service use was calculated as any inpatient or outpatient depression or 
anxiety service, any inpatient depression or anxiety hospitalization, any outpatient depression 
or anxiety service, any outpatient psychotherapy, and any outpatient medication management 
per month. Intensity of service use was calculated as the average total number of outpatient 
depression or anxiety services, psychotherapy, and medication management per person per 
month, conditional on using the service. Total and out-of-pocket spending were calculated 
as average dollars spent on inpatient, outpatient, and prescription drug services per person 
per month, adjusted for inflation to 2012 dollars using the Consumer Price Index. Total 
spending included the total amount due to a provider including the out-of-pocket amount 
due. Out-of-pocket spending included deductibles, coinsurance, and copayments. 
Analyses 
 A single group interrupted time series design was used to measure the association of 
the federal parity law with the outcomes of interest, which were aggregated to the month 
level for analyses. Data were analyzed with SAS statistical software using the AUTOREG 
procedure to obtain estimates based on the Yule-Walker method to correct for first-order 
autocorrelation [82]. Regression models included a binary indicator for policy period (pre-
parity and post-parity) to estimate changes in outcomes at the time of implementation; a 
continuous term for month to estimate time trends across the study period; and an 
interaction term for policy period and month to estimate changes in time trends attributable 
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to implementation. Models also included a binary indicator for each calendar month to 
adjust for seasonal variation in outcomes. 
Results 
Baseline demographic and clinical characteristics of enrollees 26-33 years old with 
depression and anxiety diagnoses are shown in Table 3.1. The baseline characteristics 
represent the first year each individual had a depression or anxiety diagnosis and continuous 
enrollment. The sample was mostly female, but the proportion of female enrollees decreased 
slightly over the study period. The average age was about 30 years old across the study 
period. Most enrollees lived in the southern census region and in non-rural areas. A minority 
of individuals had both a depression and anxiety diagnosis in the first study year (12.8%), but 
the proportion with both depression and anxiety diagnoses increased over time. Among 
those with either a depression or anxiety diagnosis alone, a larger proportion of the sample 
had only a depression diagnosis in the first study year (49.7%), but a larger proportion had 
only an anxiety diagnosis by the end of the study period (48.1%). About 20% of the sample 
had a comorbid mental illness other than depression or anxiety, with a slight increase over 
the study period. Few enrollees used inpatient depression or anxiety services and most used 
outpatient services. Less than half of enrollees used outpatient psychotherapy, and a 
minority used outpatient medication management.  
Interrupted time series estimates are shown in Table 3.2. Some increases were found 
in the probability of using services at the time the parity law was implemented and in the 
trends in service use over time after implementation. At the time of implementation, the 
probability of inpatient depression- or anxiety-related hospitalizations increased (p=0.006), 
but no changes were detected in the probability of using outpatient depression or anxiety 
services (p=0.212). The probability of psychotherapy decreased (p=0.001), but the 
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probability of medication management did not change (p=0.168). The decrease in 
psychotherapy translated to a 23.3% lower probability of using psychotherapy services by the 
end of the study period over the expected probability without implementing the parity law 
(Figure 3.1).  
After implementation, trends in the probability of inpatient depression- or anxiety-
related hospitalizations decreased (p=0.035), but the decreased rate of inpatient service use 
was too small to offset the initial increase at implementation. For example, the estimates for 
using inpatient depression or anxiety services amounted to a 0.3% higher probability of 
hospitalization by the end of the study period over the expected probability in the absence of 
parity. No changes were detected in trends for the probability of using outpatient depression 
or anxiety services (p=0.523) or psychotherapy (p=0.991), but trends in the probability of 
medication management increased (p=0.011). By the end of the study period, the increased 
rate of medication management totaled 6.2% higher probability of using medication 
management services over the expected probability in the absence of parity (Figure 3.2). 
Similar to outcomes for the probability of using services, some increases were found 
in the quantity of services used per person per month at the time the law was implemented 
and in the trends over time after implementation. At implementation, a marginally significant 
decrease in quantity of use was detected for outpatient depression or anxiety services 
(p=0.055); no change was detected for psychotherapy (p=0.717); and the quantity of 
medication management significantly increased (p=0.007). After implementation, trends in 
the quantity of outpatient depression and anxiety services (0.138) and psychotherapy (0.596) 
remained steady, but trends in the quantity of medication management (p=0.045) increased. 
Increases in the quantity of medication management services used were small, totaling less 
than one additional visit per person by the end of the study period.  
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There were no significant changes in total (p=0.445) or out-of-pocket (p=0.701) 
mental health spending at the time the parity law was implemented. After implementation, 
trends in total mental health spending decreased (p=0.038), corresponding to a $75 decrease 
per person by the end of the study period over expected spending in the absence of the law. 
There were no changes in out-of-pocket spending (p=0.763).  
Discussion 
 This study indicates that the federal parity law had a modest effect on mental health 
service use and spending among adults 26-33 years old with depression and anxiety 
diagnoses. At the time the parity law was implemented, the probability of using inpatient 
depression or anxiety services increased while the probability of using psychotherapy 
decreased. This pattern of results could arise directly through increased access to hospital-
based care that was medically needed but inaccessible prior to the parity law due to financial 
and treatment limitations. Alternatively, increased inpatient utilization could result from 
increased access to ambulatory care that recognizes and refers individuals to inpatient 
treatment; however, no evidence was found of increases in the probability of using 
outpatient depression or anxiety services overall. 
After implementation, trends in the probability of using inpatient depression or 
anxiety services decreased while the probability of using outpatient medication management 
increased. This pattern suggests that the parity law had contrasting short-term and longer-
term effects, with increased inpatient use initially and increased outpatient medication 
management over time after implementation. In addition, insurers might have responded to 
early increases in inpatient care by modifying benefit structures or adopting new strategies to 
manage care and encourage outpatient treatment, which can reduce the need for more 
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expensive hospital-based care. Changes in the quantity of outpatient service use associated 
with implementing the parity law also reflect these potential explanations.  
The number of services used per person per month decreased at the time of 
implementation for users of outpatient depression or anxiety services and increased for users 
of outpatient medication management. Trends in the quantity of medication management 
also increased after implementation. As discussed in relation to findings for the probability 
of service use outcomes, hospital-based care may have become more accessible when the law 
was implemented. In that case, individuals with more intensive treatment needs might have 
accessed treatment in inpatient rather than outpatient settings, driving a decrease in the 
average quantity of outpatient services used at the time of implementation. This possibility is 
consistent with previous research suggesting parity implementation had particularly marked 
effects for individuals who were high intensity service users in the pre-parity period [34]. 
Within the outpatient setting, higher intensity medication management with no changes in 
psychotherapy could reflect important differences in the association between the parity law 
and specific services.  
While access to psychotherapy could have improved as a result of the parity law, 
relative improvements in financial protection and access to other services may have been 
greater since many providers do not accept private insurance as payment for psychotherapy 
and other specialty psychiatric services [83]. Federal parity requirements applied to out-of-
network benefits covering such services, yet the inability of insurers to negotiate lower rates 
with non-participating providers typically results in higher total and out-of-pocket spending 
that could remain a barrier to psychotherapy treatment as access to other treatment 
modalities improved after the law was implemented. Furthermore, the shifts away from 
psychotherapy toward both inpatient and outpatient alternatives could indicate differences in 
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illness severity. Both psychological and pharmacological treatments can be effective, but 
research has suggested that depression is commonly treated with psychotherapy in the acute 
phase and with medication once remission has been achieved [4, 84].  
Although changes in service use associated with the federal parity law were 
significant among adults 26-33 years old with depression and anxiety diagnoses, the estimates 
were small. Likewise, the parity law was associated a small decrease in the trend for average 
total mental health spending, but no changes in average out-of-pocket spending. These 
findings fail to demonstrate the same improvements in financial protection for beneficiaries 
as had been found in prior studies examining spending for services to treat autism spectrum 
disorders and substance use disorders [36, 37]. These results could indicate that services for 
depression and anxiety were nearly in compliance with parity requirements prior to the law’s 
implementation. In that case, achieving full compliance might have produced small shifts in 
utilization like those found here without substantially impacting spending or improving 
financial protection for enrollees. The discrepancy between findings may also reflect 
differences across the study group definitions.  
This study examined a typically healthy age group and relatively common mental 
illnesses with outpatient treatment options that can be effective for many people [4]. In 
contrast, treatment for autism spectrum disorders is often more specialized and intensive, 
reflected by higher average annual total mental health spending per person [36]. The study 
examining substance abuse treatment focused on out-of-network services, which are 
inherently more expensive [37]. Possibly, the parity law had the greatest impact on access to 
care and financial protection for disorders with more expensive treatments since higher cost 
services and subgroups could have been clear targets for treatment limitations and 
disproportionate cost sharing requirements before parity became law.  
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The main limitation of this study is the lack of a comparison group that was not 
impacted by parity requirements. The MHPAEA was a federal policy that applied to large 
group plans and the data included insurance claims from large employer-sponsored plans. 
While these insurers were precisely those targeted by the federal parity law, the scope of both 
the policy and the dataset limited the potential to identify an appropriate comparison group. 
As a result, secular changes could have influenced the outcomes measured. A key concern 
for this analysis was the possible impact of other health reform occurring during the study 
period, specifically, the passage of the ACA shortly after the parity law was implemented in 
2010. Most major ACA provisions went into effect after the study period ended, but the 
dependent coverage expansion targeting young adults was implemented at the beginning of 
2011. To exclude young adults whose service use and spending could have been impacted by 
the ACA, the sample was limited to those 26-33 years old who were not eligible for 
dependent coverage.  
In addition, the large group insurance claims analyzed here were drawn from a 
convenience sample. Although the dataset includes around 20 million covered lives each 
year, the results are not necessarily generalizable to all individuals covered by large group 
insurance plans. Therefore, the association between the federal parity law and mental health 
service use and spending in other insured populations may differ from the results shown 
here. Furthermore, the relationship between the law and mental health service use and 
spending may arise through multiple pathways that could not be evaluated using insurance 
claims, such as through changes in providers’ clinical or administrative practices. 
Nonetheless, the results provide the first assessment of the aggregate association between 
the federal parity law and mental health service use and spending among young adults with 
depression and anxiety diagnoses. 
 48 
Conclusion 
Although changes in service use associated with implementation of federal parity 
requirements were small, the results highlight the potential importance of the range of 
services that are accessible and affordable among privately insured young adults with 
depression and anxiety diagnoses. For federal parity to achieve the goal of improving access 
to care without incurring substantial increases in spending, it could be beneficial to consider 
benefit structures or payment models to remove persistent barriers to care and ensure 
options for treatment. More research is needed to understand the comprehensive impact of 
reforms across mental health populations and care settings. Future studies should continue 
to evaluate effects over time, including those related to key components of the MHPAEA 
that took effect with the interim and final rules in 2014 [85].  
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Table 3.1 Unadjusted baseline characteristics of young adults 26-33 years old with depression and anxiety diagnoses 
 Pre-MHPAEA Post-MHPAEA 
 2007 2008 2009 2010 2011 2012 
 N % N % N % N % N % N % 
 65,601   70,356   68,530   66,486   71,072   74,660   
Mean Age 29.9   29.7   29.6   29.6   29.6   29.5   
Sex                         
Female 46,171 70.4 48,872 69.5 47,138 68.8 45,527 68.5 48,919 68.8 50,514 67.7 
Census Region                         
Northeast 9,591 14.6 11,329 16.1 10,615 15.5 9,944 15.0 10,620 14.9 11,537 15.5 
Midwest 17,471 26.6 17,268 24.5 15,831 23.1 14,658 22.0 14,649 20.6 17,369 23.3 
South 25,867 39.4 26,657 37.9 25,707 37.5 25,010 37.6 29,539 41.6 26,773 35.9 
West 12,672 19.3 15,102 21.5 16,377 23.9 16,874 25.4 16,264 22.9 18,981 25.4 
Urban/rural                         
MSA 56,996 86.9 62,661 89.1 60,831 88.8 59,265 89.1 63,286 89.0 67,008 89.8 
Diagnoses                         
Depression alone 32,606 49.7 33,026 46.9 30,176 44.0 27,458 41.3 27,566 38.8 26,378 35.3 
Anxiety alone 24,576 37.5 28,391 40.4 29,004 42.3 29,189 43.9 32,774 46.1 35,938 48.1 
Depression and anxiety 8,419 12.8 8,939 12.7 9,350 13.6 9,839 14.8 10,732 15.1 12,344 16.5 
Comorbidities                         
Any mental illness 12,817 19.5 14,158 20.1 13,931 20.3 13,852 20.8 14,806 20.8 15,854 21.2 
   Bipolar disorder 3,067 4.7 2,975 4.2 2,822 4.1 2,475 3.7 2,445 3.4 2,557 3.4 
   Substance use disorder 2,092 3.2 2,408 3.4 2,356 3.4 2,502 3.8 2,757 3.9 3,062 4.1 
Service use             
Any inpatient depression or anxiety service use 1,045 1.6 1,358 1.9 1,582 2.3 1,787 2.7 1,857 2.6 1,895 2.5 
Any outpatient depression or anxiety service use 65,326 99.6 70,077 99.6 68,212 99.5 66,195 99.6 70,772 99.6 74,336 99.6 
Average outpatient depression or anxiety visits 
per year among users 6.38   6.12   5.88   5.92   6.17   6.42   
Any outpatient psychotherapy service use 29,860 45.5 30,382 43.2 27,913 40.7 25,907 39.0 27,529 38.7 28,623 38.3 
Average outpatient psychotherapy visits per year 
among users 9.63   9.38   9.00   9.06   9.51   9.50   
Any outpatient medication management service use 10,232 15.6 8,708 12.4 7,321 10.7 6,737 10.1 6,820 9.6 6,954 9.3 
Average outpatient medication management visits 
per year among users 3.60   3.42   3.36   3.45   3.38   3.39   
Any psychotropic medication use 47,006 71.7 49,771 70.7 48,714 71.1 47,248 71.1 50,573 71.2 52,838 70.8 
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Table 3.2 Interrupted time series estimates of mental health service use and spending among 
young adults 26-33 years old with depression or anxiety 
    
Probability of service use %a SE p 
Inpatient or outpatient depression or anxiety    
Month 0.0202 0.0079 0.014 
Parity -0.2990 0.2370 0.212 
Parity*Month 0.0054 0.0108 0.621 
Inpatient depression or anxiety    
Month 0.0002 0.0002 0.439 
Parity 0.0201 0.0071 0.006 
Parity*Month -0.0007 0.0003 0.035 
Outpatient depression or anxiety    
Month 0.0075 0.0074 0.318 
Parity -0.2799 0.2214 0.212 
Parity*Month 0.0065 0.0101 0.523 
Psychotherapy    
Month 0.0086 0.0061 0.166 
Parity -0.6457 0.1826 0.001 
Parity*Month -0.0001 0.0084 0.991 
Medication management    
Month -0.0172 0.0016 0.000 
Parity 0.0667 0.0477 0.168 
Parity*Month 0.0058 0.0022 0.011 
Intensity of outpatient service use among users Nb SE p 
Depression or anxiety    
Month 0.0047 0.0006 <0.001 
Parity -0.0353 0.0181 0.055 
Parity*Month 0.0012 0.0008 0.138 
Psychotherapy    
Month 0.0029 0.0009 0.002 
Parity -0.0096 0.0263 0.717 
Parity*Month -0.0006 0.0012 0.596 
Medication management    
Month -0.0008 0.0002 <0.001 
Parity 0.0146 0.0052 0.007 
Parity*Month 0.0005 0.0002 0.045 
Mental Health Spending $c SE p 
Total    
Month 0.32 0.07 <0.001 
Parity 1.57 2.03 0.445 
Parity*Month -0.20 0.09 0.038 
Out-of-pocket    
Month 0.02 0.03 0.437 
Parity 0.29 0.75 0.701 
Parity*Month 0.01 0.03 0.763 
Note: Results were estimated using Yule-Walker regression models to correct for first-order autocorrelation. 
The estimates of interest include the binary policy period indicator, which represents changes in the outcome 
when the parity law was implemented, and the interaction between the policy period and month, which 
represents changes in the time trend as a result of parity implementation.  
a Values are regression estimates of percentage who used services 
b Values are regression estimates of average services per person per month among individuals who used 
services 
c Values are regression estimates of average dollars per person per month 
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Figure 3.1 Difference in the probability of using outpatient psychotherapy services between 
observed rates and predicted rates in the absence of parity 
Figure 3.2 Difference in the probability of using outpatient medication management services 
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Objective: The purpose of this study was to examine depression screening patterns and the 
role of screening in depression diagnosis and treatment in primary care settings.  
Methods: Data were drawn from the 2005-2014 National Ambulatory Medical Care Surveys 
(NAMCS), which is nationally representative of visits to outpatient physician offices. 
Logistic regression was used to estimate the odds of depression screening, diagnosis, and 
treatment in order to assess the correlates of each of these stages of depression care. Logistic 
regression with propensity score weighting was used to estimate the odds of depression 
diagnosis and treatment under the counterfactual simulation that patients who visited 
providers with low screening rates had instead gone to providers with higher screening rates. 
Results: A small proportion of outpatient primary care visits included depression screening. 
Visits by patients with depression symptom complaints were associated with higher odds of 
depression screening than visits by patients who reported other complaints. Screening was 
associated with higher odds of diagnosis and treatment, even when accounting for presence 
of symptoms. When visits were weighted to have similar demographic and clinical 
characteristics (e.g. sex, age, race/ethnicity, chronic comorbidities) as visits to providers with 
low screening rates, visits to providers with higher screening rates had higher odds of 
depression diagnosis and treatment than visits to providers with lower screening rates, 
indicating that if patients visiting providers with low screening rates instead visited providers 
with higher screening rates they would be more likely to be diagnosed.  
Conclusions: The results suggest physicians may target patients for screening based on their 
symptoms and indicate that screening is associated with increased depression identification 
and treatment, particularly for visits with patients who have risk factors for depression. 
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Findings suggest raising screening rates could potentially increase depression identification 




Primary care is the main point of access to health care in the U.S., visited by most 
Americans for routine checkups and new health problems, including issues that could 
require specialty care [40]. Consequently, general medical providers, rather than specialty 
mental health providers, encounter a large proportion of the population with depression. 
General medical providers have also assumed much of the responsibility for treating 
depression, largely due to medication advances and the rise of managed care [42, 86]. Yet, 
estimates suggest 75-85% of primary care patients with depression remain untreated [41, 43].  
Low treatment rates can be partially explained by low identification rates since over 
half of primary care patients with depression are undiagnosed, although some patients are 
treated for depression without a diagnosis [43]. In fact, antidepressant prescriptions without 
a psychiatric diagnosis have driven the overall rise in antidepressant use over time [87]. 
Treatment without a psychiatric diagnosis could signal inappropriate treatment of subclinical 
symptoms, off-label prescribing practices, or impediments to proper diagnosis, such as 
fragmented medical and mental health care [87]. Regardless of treatment decisions, evidence 
shows primary care doctors sometimes diagnose patients’ somatic complaints (e.g. fatigue, 
insomnia, or headache) that may indicate depression in place of diagnoses for depression 
and other mental illnesses [58, 59]. Physicians report diagnostic uncertainty as the primary 
reason for diagnosing alternatives to depression [58, 59].  
Doubts about diagnosis reflect two central issues in modern depression care and 
mental health care more broadly. First, diagnosing mental illness requires meeting a 
threshold of symptoms during a specified time period [88, 89]. A depression diagnosis 
requires the presence of at least one of two key symptoms as well as a minimum of four 
additional symptoms out of nine total symptom criteria, and symptoms must persist for at 
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least two weeks [88, 89]. Because there are no existing biological tests and depression 
includes a symptom profile that healthy people experience to varying degrees in daily life, 
identifying depression at a clinical threshold for diagnosis is complicated. Second, many 
primary care physicians have limited specialty training in mental health care, resulting in a 
lack of expertise and confidence related to diagnosing and treating mental illnesses [90].  
Depression screeners have been developed to address diagnostic uncertainty. Based 
on evidence of their utility in primary care settings, the United States Preventive Services 
Task Force (USPSTF) recommends routine depression screening for adolescents and adults 
12 years old and older; however, optimal screening intervals are not specified [91, 92]. Critics 
have argued that evidence supporting universal depression screening in primary care is 
deficient and have expressed concerns that practices based on these recommendations could 
fail to improve depression-related health outcomes for patients in primary care settings [93]. 
The USPSTF acknowledges that “direct evidence of the isolated health benefit of depression 
screening in primary care is weak” and that some patients with depression will not receive 
adequate treatment even with screening and diagnosis [51]. The USPSTF also recognizes 
concerns about false positives and unnecessary treatment raised by critics, but concludes that 
the benefits of screening outweigh the potential harms [51, 93]. Yet, depression screening is 
rare in primary care settings, suggesting that physicians continue to rely on their clinical 
judgment to diagnose depression or to screen patients only under certain circumstances [94, 
95]. 
Considering the apparent division between current recommendations and practice, 
the purpose of this study was twofold. One objective was to examine current practices for 
evidence of targeted screening by analyzing the correlates of depression screening in primary 
care. Higher odds of screening were hypothesized for visits in which patients reported a 
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depression symptom as their primary complaint compared to those reporting other reasons 
for the visit since these symptoms may signal to providers to confirm or rule out depression 
when diagnosing and treating patients.  
A second objective was to estimate the relationship between screening and 
depression diagnosis and treatment outcomes, including the potential impact of increasing 
screening rates on rates of diagnosis and treatment. To do this, the association between 
screening and depression diagnosis and treatment was examined, hypothesizing higher odds 
of both diagnosis and treatment for visits in which screening was conducted compared to 
visits without screening. Then, the relationship between screening rates and depression 
diagnosis and treatment outcomes was assessed by comparing visits to providers with higher 
screening rates to visits to providers with lower screening rates. Higher odds of diagnosis 
and treatment were hypothesized for visits to providers with higher screening rates 
compared to visits to providers with lower screening rates. Since provider screening rates 
could reflect differences in their patient populations instead of differences in their screening 
practices, propensity score weighting was used to address potential confounding by patient 
characteristics that might influence provider screening rates, such as depression symptoms 
and other measures of health status. Propensity score weights controlled for observed 
patient characteristics to examine diagnosis and treatment outcomes as if patients who 




Data were from the National Ambulatory Medical Care Survey (NAMCS), which is a 
nationally representative survey of outpatient visits to physician offices conducted annually 
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by the National Center for Health Statistics (NCHS). Census Bureau representatives fielded 
data collection each year, which relied largely on physician respondents until 2012 when 
computer-assisted technology was introduced to extract information from visit records with 
a quality control protocol to ensure comparability across years [96]. NAMCS includes patient 
characteristics, diagnostic and prescription medication information, and encounter-level 
details. Analyses were conducted using data from 2005-2014, the most recent available 
survey year at the time of these analyses. 
Sample 
 The sample included visits with adolescents and adults 12 years old and older 
because the USPSTF depression screening recommendations apply to this age group. 
General medical care was defined as visits to providers who specialize in general or family 
medicine, internal medicine, pediatrics, or obstetrics and gynecology. The primary 
motivation was to understand screening as a detection tool rather than as a monitoring tool; 
therefore, visits were included if the major reason for the visit was identified as preventive or 
acute care. Additionally, the sample was limited to visits by patients who had no prior-year 
visits in order to exclude visits by patients who could have been screened during a previous 
visit. 
Measures 
Complaints, symptoms, or other reasons for the visit in the patient’s own words are 
recorded for each visit and coded according to a classification system designed for NCHS 
[97]. If the patient’s primary reason for the visit was a symptom category indicative of 
depression criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM) that 
might be predictive of possible depression, then the primary complaint was categorized as a 
depression symptom [88]. These symptom categories included depression (e.g. sadness, 
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hopelessness); tiredness/exhaustion (e.g. fatigue, lack of energy); abnormal appetite (e.g. 
excessive appetite, decreased appetite); weight gain or loss; anxiety/nervousness (e.g. upset, 
worried); sleep disturbances (e.g. trouble falling asleep, sleepiness); restlessness; memory 
problems (e.g. forgetfulness), lack of libido (e.g. loss of sex drive), self-esteem problems (e.g. 
guilt, lack of motivation) and other mental health-related symptoms (e.g. can’t cope, danger 
to self).  
Depression screening was among a checklist of the diagnostic and screening services 
that were ordered or provided during the visit. For this study, visits were identified as 
including depression screening if depression screening was indicated on the record. Provider 
screening rates were calculated as the number of visits with a depression screening out of all 
initial yearly visits sampled for each provider. 
Up to three diagnoses were recorded for each patient visit, which were coded 
according to the International Classification of Diseases, Ninth Revision, Clinical 
Modification (ICD-9-CM) [70]. An additional item asked, “Regardless of the diagnoses 
previously listed, does the patient now have depression”? For the purposes of this study, 
depression diagnosis was defined as either an ICD-9-CM code for depression corresponding 
to DSM-IV-TR depression diagnoses (296.2, 296.3, 300.4, and 311) or an affirmative 
response to the additional item indicating the patient had depression [98]. 
Both medication and non-medication treatment were recorded if they were ordered 
or provided during the visit. For this study, depression treatment was defined as either 
psychotherapy or antidepressant medication. Psychotherapy was identified by records 
indicating that either psychotherapy or other mental health counseling was ordered or 
provided during the visit. Medications were coded by NCHS according to their components 
and therapeutic classification using a proprietary database [99]. Antidepressant treatment was 
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identified by records indicating any medication in the therapeutic class of antidepressants 
was ordered or provided during the visit. The antidepressant class encompassed selective 
serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), monoamine oxidase 
inhibitors (MAOIs), tetracyclic antidepressants (TeCAs), selective serotonin-norepinephrine 
reuptake inhibitors (SSNRIs), phenylpiperazine antidepressants, and miscellaneous 
antidepressants.  
Additional characteristics associated with depression care in previous research in 
primary care settings were included [100-103]. Measures of demographic and clinical 
characteristics included patient sex, age, race/ethnicity, insurance, census region, urban/rural 
area measured by metropolitan statistical area (MSA), and the presence of any comorbid 
chronic condition (defined in the visit record as arthritis, asthma, cancer, cerebrovascular 
disease, congestive heart failure, chronic renal failure, chronic obstructive pulmonary disease, 
diabetes, hyperlipidemia, hypertension, ischemic heart disease, obesity, and osteoporosis). 
Covariates associated with the clinical encounter included patient status (new or established); 
physician status as the patient’s primary care provider; visit type (preventive or acute care); 
and the year in which the visit occurred.  
Analyses 
Data were analyzed using the svy suite of commands for survey data in Stata 
statistical software, Version 13.1 [72]. NCHS guidelines were followed to account for the 
complex, multi-stage sampling design, incorporating patient visit weights to obtain estimates 
that are nationally representative of outpatient visits at the patient level [104].  
Logistic regressions separately estimated the odds of depression screening, diagnosis, 
and treatment among outpatient primary care visits. The screening outcome compared 
patients who reported a depression symptom as their primary complaint to those reporting 
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other reasons for the visit. The diagnosis and treatment outcomes compared visits in which 
screening was conducted to visits without screening. Predicted probabilities of depression 
diagnosis and treatment were computed, comparing screening across patient complaints 
(depression symptoms and other reasons for the visit) to assess how the effect of screening 
differed by the primary reason for the visit. All models adjusted for the patient and 
encounter characteristics described above.   
To examine the relationship between provider screening rates and depression 
diagnosis and treatment outcomes, visits to providers with higher screening rates were 
compared to visits to providers with lower screening rates. Screening rates were calculated 
among the visits sampled for each provider, and the provider rates were summarized using 
survey weights to obtain estimates that are representative of outpatient visits at the physician 
level. The distribution of provider screening rates was used to define high-rate screeners as 
providers with screening rates at or above the 95th percentile.  
The goal was to estimate diagnosis and treatment outcomes in relation to provider 
screening rates, but screening rates could reflect differences either at the provider level or 
across the patients who visit them. To account for potential differences in the patient 
populations seen by providers with high (≥ 95th percentile) and low (< 95th percentile) 
screening rates, propensity score weighting was used to balance visits to higher-rate screeners 
with visits to lower-rate screeners in terms of providers’ patient panels.  
First, propensity scores were calculated from a logistic regression predicting the 
probability of visiting a provider with a low screening rate based on observed demographic 
and clinical characteristics that may influence screening. The model incorporated direct 
measures of health, including the presence of a chronic condition and depression symptom 
reporting, in addition to patient characteristics that are predictive of health status and health 
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care utilization, including sex, age, race/ethnicity, insurance, census region, and urban/rural 
area. Propensity score estimates also incorporated survey sampling weights but no other 
survey design variables (i.e. strata and clusters) [105].  
Then, inverse probability of treatment weights (IPTW) were calculated from the 
propensity scores to weight visits to providers with higher screening rates. The weighted 
group of visits to higher-rate screeners and the group of visits to lower-rate screeners were 
well balanced in terms of demographic and clinical characteristics. New weights were 
calculated from the product of IPTW and survey sampling weights and then applied with the 
survey design variables to models for depression diagnosis and treatment in order to obtain 
estimates that are nationally representative of outpatient visits by patients who visited 
providers with low screening rates [105]. This weighting scheme allowed the diagnosis and 
treatment outcomes of interest to be examined as if the patients who went to providers with 
lower screening rates had instead gone to providers with higher screening rates. 
Results 
Sample characteristics of initial annual outpatient visits to general medical providers 
by adolescents and adults 12 years old and older are presented in Table 4.1. The sample 
(N=16,447) represented visits by patients who were mostly female (64.7%), white (69.8%), 
privately insured (65.2%), and living in more urban areas (89.5%). Depression symptoms 
were reported as the patient’s primary complaint for 2.2% of visits, and depression screening 
occurred in 3.0% of visits overall. Screening was conducted in 10.5% of visits in which 
depression symptoms were the primary patient complaint, as opposed to 2.8% of visits in 
which other complaints were the primary reason for the visit (data not shown). Depression 
was identified in 6.1% of visits, and depression treatment was ordered or provided in 7.5% 
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of visits. Overall, 3.1% of visits included both a depression diagnosis and treatment (data not 
shown). 
Adjusted regression results for depression screening, diagnosis, and treatment are 
presented in Table 4.2. Visits were associated with higher odds of depression screening if a 
depression symptom was the patient’s primary complaint (OR=5.57, p<0.001). Additional 
correlates associated with higher odds of screening included comorbid chronic conditions 
(OR=1.42, p=0.011), female sex (OR=1.39, p=0.032), identifying the physician as the 
primary care provider for the patient (OR=1.44, p=0.042), and identifying the visit as 
preventive care (OR=2.77, p<0.001). Living in the West was associated with lower odds of 
screening (OR=0.42, p=0.007).  
Visits were associated with higher odds of depression diagnosis if screening was 
conducted (OR=4.13, p<0.001) and if a depression symptom was the patient’s primary 
complaint (OR=7.72, p<0.001). The association between screening and the probability of 
depression diagnosis was stronger for visits with depression symptom complaints than for 
visits with other complaints (Figure 4.1). Additional correlates associated with higher odds of 
depression identification included female sex (OR=1.95, p<0.001), early (OR=1.58, 
p=0.004) to middle adulthood (OR=1.54, p=0.009), public insurance, living in the Midwest 
(OR=1.75, p=0.004) or the West (OR=1.54, p=0.020), and identifying the physician as the 
primary care provider for the patient (OR=1.22, p=0.044). Characteristics associated with 
decreased odds of diagnosis were adolescent age (OR=0.43, p=0.001), black (OR=0.54, 
p<0.001) or other race (OR=0.49, p=0.004), and self-pay status (OR=0.68, p=0.048). 
Visits were associated with higher odds of depression treatment if screening was 
conducted (OR=1.83, p=0.007) and if a depression symptom was the patient’s primary 
complaint (OR=3.52, p<0.001). The association between screening and the probability of 
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depression treatment was slightly stronger for visits with depression symptom complaints 
than for visits with other complaints (Figure 4.1). Additional correlates associated with 
higher odds of treatment were depression diagnosis (OR=15.53, p<0.001), female sex 
(OR=1.51, p<0.001), early and middle ages, living outside the Northeast, and time 
(OR=1.06, p<0.001). Characteristics associated with decreased odds of treatment were 
adolescent ages (OR=0.40, p<0.001), black (OR=0.66, p=0.008) and other races (OR=0.57, 
p=0.004), self-pay (OR=0.56, p=0.009) or other insurance status (OR=0.60, p=0.001).  
While depression screening occurred in 3.0% of visits overall, providers varied in the 
frequency of depression screening within their sampled visits. On average, providers 
(N=4,289) screened in 3.1% of their sampled visits, but the median screening rate was 0.0%. 
Providers at or above the 95th percentile of screening rates screened in 5% or more of their 
visits and were categorized as high rate screeners (N=274 providers).  
Sample characteristics before and after weighting visits to have similar demographic 
and clinical characteristics as visits to providers with low screening rates are presented in 
Table 4.3. Before weighting, most demographic characteristics of visits to providers with 
higher screening rates were not significantly different from visits to providers with lower 
screening rates; however, a higher proportion of visits to providers with higher screening 
rates were with patients who reported a depression symptom as the primary reason for the 
visit (p=0.010). After propensity score weighting, there were no significant differences in 
demographic and clinical characteristics between visits to providers with higher and lower 
screening rates.  
Adjusted regression results for diagnosis and treatment comparing visits by 
demographically and clinically similar patients to providers who screened at higher rates with 
providers who screened at lower rates are presented in Table 4.4. Visiting a provider who 
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screened at rates above the 95th percentile of screening rates was associated with increased 
odds of depression diagnosis (OR=1.96, p<0.001) and treatment (OR=1.60, p=0.001). This 
translates into a 4.5% higher probability of depression diagnosis (95% CI=2.7-6.4) and a 
3.3% higher probability of depression treatment (95% CI=1.2-5.4) for visits to providers 
with higher screening rates compared to visits to providers with lower screening rates 
(Figure 4.2). 
Discussion 
In this nationally representative study of initial annual visits to outpatient primary 
care settings, a relatively small percentage of physicians screened patients for depression. 
Despite evidence that depression screening has good diagnostic accuracy in primary care, the 
low rates of screening in general medical settings suggest that most physicians rely on their 
clinical judgment to identify cases or refer potential cases to specialists [50, 106]. Others 
might overlook depression altogether due to resource or time constraints; although, most 
depression screeners are brief, easy to score and interpret, validated for use in multiple 
populations, and effective for both detection and monitoring. Furthermore, two-question 
screeners have been developed and validated for use in both adult and adolescent 
populations to address primary care providers’ many responsibilities and often brief visit 
times [107, 108]. Nonetheless, the association between depression screening and clinical risk 
factors, including depression symptom complaints and comorbid chronic conditions, 
indicate that providers might target higher risk patients when they conduct depression 
screening.  
The findings also showed an association between these risk factors and depression 
diagnosis and treatment outcomes when controlling for screening, suggesting providers 
identify and treat higher risk patients regardless of whether their decisions are aided by 
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depression screening; although, the relationship between depression symptom complaints 
and diagnosis was dependent on whether screening was conducted. The difference in the 
probability of diagnosis between visits with patients who reported depression symptom 
complains and those who reported other reasons for the visit was higher when screening was 
conducted. This result could suggest that providers who fail to recognize depression 
symptom complaints as related to possible depression might not identify depression in the 
absence of screening. Another possibility is that this result reflects improved predictive 
accuracy of screening tools when applied to a group with higher depression prevalence, 
assuming patients with depression symptom complaints are simply more likely to have 
depression.  
When visits were weighted to have similar patient characteristics as visits to 
providers with lower screening rates, the results indicated that the probability of depression 
diagnosis and treatment would be higher if patients who visited providers with lower 
screening rates instead went to providers with higher screening rates. Since weights 
incorporated demographic and clinical characteristics, including whether depression 
symptoms were reported as the primary reason for the visit, these findings suggest 
depression identification and treatment might be increased if providers had higher screening 
rates regardless of their case-mix. Nonetheless, additional characteristics that were not 
included in the weights could have differed between patients who visited providers with 
higher and lower screening rates. One limitation of this analysis was unobserved or 
incomplete patient data that could have affected the extent to which patients visiting 
providers with higher and lower screening rates had comparable demographic and clinical 
characteristics.  
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For example, health status was measured by the presence or absence of a comorbid 
chronic condition, but lifestyle factors like exercise and tobacco use could also be important 
indicators of the health of each patient population. Although exercise information is not 
recorded, the NAMCS includes both body mass index (BMI)—calculated from direct clinical 
measures of height and weight—and tobacco use. Due to a high proportion of missing 
values in this sample of visits, neither BMI nor tobacco use were included in the weights. In 
addition, the data did not include indicators of socioeconomic status (SES), which is 
correlated with health and access to care. Health insurance served as a proxy for SES, but 
information about patients’ education, income, or occupation might have improved balance 
between patient populations.  
Furthermore, the public survey data restricted the physician characteristics that were 
available for analyses. Physicians had low screening rates overall, with few physicians 
screening at rates higher than 5% of initial annual visits and almost none screening 
universally in all their sampled visits. Without more information about physicians, it was not 
possible to assess or adjust for provider characteristics that potentially were associated with 
screening at a higher or lower rate. In addition to demographic data, information about 
physicians’ training, experience, and practice characteristics could help explain differences in 
screening rates where they exist and could offer insight about variation across providers that 
is unrelated to depression care. While the results showed that higher screening rates were 
associated with higher diagnosis and treatment rates, focus areas for raising screening rates 
are inconclusive.  
Moreover, this analysis was limited by the inability to evaluate implications for 
current recommendations to screen universally in relation to depression symptom severity or 
potential need for treatment since screening results were not available. Thus, the extent to 
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which higher diagnosis rates arise from false positive screening and higher treatment rates 
represent unnecessary treatment could not be determined.  
Finally, a general limitation of cross-sectional data is that temporality cannot be 
determined. For this study, cross-sectional data precluded following patients over time or 
determining the order of depression care processes within a visit. For example, a visit with a 
depression symptom complaint, screening, diagnosis, and treatment could reflect either a 
patient who presents with a depression symptom and then receives screening, diagnosis, and 
treatment or a patient who was previously diagnosed, but experiences persistent symptoms 
that are monitored using screening and treated continuously. While depression detection is 
the main goal of screening and might represent the purpose of screening for the majority of 
visits in which screening is conducted, the sample was limited to initial annual visits for acute 
and preventive care to exclude cases where depression screening was conducted to monitor 
symptoms.  
Although the data present challenges, this analysis benefitted from the unique survey 
structure of NAMCS, which allowed aggregate calculations at the physician level (i.e. 
depression screening rates) in addition to analyses of visits at the patient level. Consequently, 
the findings are generalizable to depression care provided in office-based outpatient visits to 
primary care providers. 
Conclusions 
Significant progress has been made to improve depression care in general medical 
settings, but important challenges remain for conventional primary care practices [44]. 
Though physicians generally find depression screening helpful, primary care settings often 
have limited personnel, time, and other resources to address mental health problems [48, 51]. 
The evidence presented here suggests targeted screening based on risk factors might be 
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typical practice and that even modest increases in targeted screening rates could also increase 
rates of depression identification and treatment. More research is needed to understand 
approaches to increase screening rates in order to ensure that high-risk groups are screened 
appropriately without exacerbating disparities in care [109].  
Aiming for universal depression screening has been recommended to improve 
detection and proposed as an approach to reduce disparities in care, but universal programs 
are also susceptible to important unintended consequences, such as substantially more false 
positives and unnecessary treatment [53, 110]. Furthermore, supports in representative 
settings may be insufficient to implement extensive interventions, whereas focused protocols 
for screening and follow-up might be more feasible. Consistent with guidelines for 
addressing depression in primary care that elaborate beyond the USPSTF screening 
recommendations, the findings presented here emphasize the importance of physicians’ 
ability to recognize the risk factors and common presentations of depression while 
highlighting the potential advantages of screening when depression is suspected [111].  
While strategic screening programs could improve depression identification and 
avoid unintended consequences, screening remains one aspect in a complex network of 
contextual influences that impact depression outcomes. Future research should incorporate 
patient outcomes whenever possible while continuing to examine the individual and 
structural factors associated with depression treatment in primary care settings [41].  
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Table 4.1 Descriptive characteristics of patient visits to outpatient primary care, stratified by 
screening status 
  Total Screened Unscreened  
 N % N % N % p 
 16,447  478 3.0 15,969 97.0  
Depression Care               
Depression Diagnosis 1,081 6.1 123 21.4 958 5.6 <0.001 
Depression Treatment 1,323 7.5 111 20.5 1,212 7.1 <0.001 
Clinical Characteristics               
Depression Symptoms 370 2.2 45 7.8 325 2.1 0.001 
Chronic Comorbidities 5,746 34.6 200 42.0 5,546 34.3 0.029 
Demographic Characteristics               
Sex               
Female 10,870 64.7 359 71.8 10,511 64.5 0.031 
Male 5,577 35.3 119 28.2 5,458 35.5 0.031 
Age               
12-17 1,775 9.9 42 9.9 1,733 9.9 0.979 
18-24 2,003 13.0 44 9.6 1,959 13.1 0.039 
25-34 2,923 18.4 76 17.3 2,847 18.4 0.648 
35-44 2,905 18.5 91 20.5 2,814 18.4 0.463 
45-54 2,722 16.6 87 16.6 2,635 16.6 0.989 
55-64 2,214 13.2 80 15.7 2,134 13.1 0.249 
65+ 1,905 10.5 58 10.5 1,847 10.5 0.996 
Race/Ethnicity               
White 11,900 69.8 345 69.4 11,555 69.8 0.907 
Black 1,687 11.2 43 9.3 1,644 11.3 0.238 
Hispanic 1,972 13.2 64 14.1 1,908 13.2 0.737 
Other 888 5.8 26 7.2 862 5.7 0.625 
Insurance               
Private 10,398 65.2 309 66.4 10,089 65.1 0.775 
Medicaid 1,341 7.8 41 7.3 1,300 7.9 0.742 
Medicare 1,717 9.6 51 10.0 1,666 9.6 0.826 
Self Pay 1,112 7.5 37 7.3 1,075 7.5 0.927 
Other 1,879 9.9 40 9.0 1,839 9.9 0.764 
Census Region               
Northeast 2,223 16.9 86 26.8 2,137 16.6 0.056 
Midwest 4,198 20.2 119 19.0 4,079 20.3 0.712 
South 5,882 39.0 171 38.8 5,711 39.0 0.967 
West 4,144 23.9 102 15.4 4,042 24.2 0.004 
MSA               
Urban 14,309 89.5 428 92.2 13,881 89.5 0.203 
Rural 2,138 10.5 50 7.8 2,088 10.5 0.203 
Encounter Characteristics               
Patient Status               
New patient 6,873 40.1 228 45.4 6,645 39.9 0.164 
Established patient 9,574 59.9 250 54.6 9,324 60.1 0.164 
Provider Status               
Patient’s PCP  9,563 57.3 255 48.5 9,308 57.5 0.046 
Not the patient’s PCP 6,884 42.7 223 51.5 6,661 42.5 0.046 
Visit Type               
Acute care 9,250 56.7 185 34.3 9,065 57.4 <0.001 
Preventive care 7,197 43.3 293 65.7 6,904 42.6 <0.001 
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Table 4.2 Adjusted regression results for depression screening, diagnosis, and treatment 
among initial annual patient visits to outpatient primary care (N=16,447) 
 Depression Screening Depression Diagnosis Depression Treatment 
 OR 95% CI p OR 95% CI p OR 95% CI p 
Depression Care           
Depression Screening          
No    1.00 Ref. — 1.00 Ref. — 
Yes     4.13 2.99-5.70 <0.001 1.83 1.18-2.85 0.007 
Depression Diagnosis                
No       1.00 Ref. — 
Yes         15.53 
12.56-
19.21 <0.001 
Clinical Characteristics                   
Depression Symptoms                   
No  1.00 Ref. — 1.00 Ref. — 1.00 Ref. — 
Yes 5.57 3.39-9.15 <0.001 7.72 
5.63-
10.59 <0.001 3.52 2.26-5.49 <0.001 
Chronic Comorbidities 1.42 1.08-1.86 0.011 1.92 1.60-2.31 <0.001 1.15 0.96-1.37 0.133 
Demographic 







Sex              
Male 1.00 Ref. — 1.00 Ref. — 1.00 Ref. — 
Female 1.39 1.03-1.87 0.032 1.95 1.55-2.44 <0.001 1.51 1.26-1.80 <0.001 
Age                   
12-17 1.39 0.78-2.47 0.258 0.43 0.26-0.71 0.001 0.40 0.25-0.64 <0.001 
18-24 1.00 Ref. — 1.00 Ref. — 1.00 Ref. — 
25-34 1.26 0.82-1.93 0.302 1.30 0.90-1.87 0.163 1.33 0.98-1.81 0.070 
35-44 1.38 0.88-2.17 0.166 1.58 1.16-2.14 0.004 1.60 1.18-2.15 0.002 
45-54 1.21 0.74-1.96 0.448 1.54 1.11-2.11 0.009 2.03 1.48-2.79 <0.001 
55-64 1.28 0.79-2.08 0.323 1.32 0.90-1.95 0.157 1.47 1.05-2.04 0.023 
65+ 1.10 0.62-1.93 0.750 0.80 0.49-1.30 0.365 1.26 0.80-1.98 0.312 
Race/Ethnicity                   
White 1.00 Ref. — 1.00 Ref. — 1.00 Ref. — 
Black 0.77 0.52-1.13 0.178 0.54 0.38-0.75 <0.001 0.66 0.49-0.90 0.008 
Hispanic 1.16 0.77-1.73 0.480 0.76 0.56-1.04 0.083 0.92 0.68-1.25 0.595 
Other 1.40 0.60-3.26 0.441 0.49 0.30-0.79 0.004 0.57 0.39-0.84 0.004 
Insurance                   
Private 1.00 Ref. — 1.00 Ref. — 1.00 Ref. — 
Medicaid 0.90 0.53-1.51 0.680 1.65 1.19-2.30 0.003 0.92 0.65-1.30 0.642 
Medicare 1.04 0.67-1.63 0.849 2.07 1.40-3.07 <0.001 1.13 0.78-1.62 0.519 
Self Pay 1.06 0.60-1.88 0.841 0.68 0.46-1.00 0.048 0.56 0.36-0.87 0.009 
Other 1.09 0.52-2.30 0.815 1.10 0.48-1.46 0.485 0.60 0.44-0.82 0.001 
Census Region                   
Northeast 1.00 Ref. — 1.00 Ref. — 1.00 Ref. — 
Midwest 0.65 0.36-1.17 0.152 1.75 1.19-2.58 0.004 1.65 1.27-2.15 <0.001 
South 0.71 0.39-1.29 0.261 1.35 0.94-1.93 0.103 1.38 1.08-1.77 0.011 
West 0.42 0.22-0.79 0.007 1.54 1.07-2.21 0.020 1.41 1.06-1.87 0.017 
MSA                  
Rural 1.00 Ref. — 1.00 Ref. — 1.00 Ref. — 
Urban 1.47 0.86-2.53 0.161 0.88 0.67-1.14 0.333 0.95 0.71-1.28 0.744 
Encounter 
Characteristics                   
Patient Status                   
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Established patient 1.00 Ref. — 1.00 Ref. — 1.00 Ref. — 
New patient 1.06 0.75-1.50 0.751 1.13 0.95-1.35 0.172 1.01 0.83-1.22 0.924 
Provider Status                   
Not the patient’s PCP 1.00 Ref. — 1.00 Ref. — 1.00 Ref. — 
Patient’s PCP 1.44 1.01-2.04 0.042 1.22 1.01-1.48 0.044 1.19 0.96-1.47 0.109 
Visit Type                   
Acute care 1.00 Ref. — 1.00 Ref. — 1.00 Ref. — 
Preventive care 2.77 2.02-3.79 <0.001 0.96 0.80-1.15 0.630 1.11 0.94-1.31 0.203 
Year 0.96 0.88-1.04 0.314 1.04 1.00-1.07 0.054 1.06 1.03-1.10 <0.001 
Note: All estimates are adjusted for patient sex, age, race/ethnicity, insurance, census region, urban/rural 
status, any comorbid chronic condition; patient status (new or established); physician status as the patient’s 
primary care provider; visit type (preventive or acute problem); and year. 
Figure 4.1 Difference in predicted probability of depression diagnosis and treatment between 
visits with and without depression symptom complaints, stratified by screening status 
Note: All estimates are adjusted for patient sex, age, race/ethnicity, insurance, census region, urban/rural 
status, any comorbid chronic condition; patient status (new or established); physician status as the patient’s 
primary care provider; visit type (preventive or acute problem); and year. Estimates for treatment are further 















Table 4.3 Descriptive characteristics of visits by patients with no prior-year visits before and 
after inverse-probability of treatment weighting, stratified by visits to providers with high 
and low screening rates 
 Unweighted Weighted 
  High-Rate  Low-Rate   High-Rate Low-Rate   
 N % N % p N % N % p 
 1,351 7.9 15,096 92.1  1,351 50.1 15,096 49.9  
Depression Care                     
Depression Diagnosis                     
Yes 172 11.1 909 5.7 <0.001 172 10.4 909 5.7 <0.001 
No 1,179 88.9 14,187 94.3 <0.001 1,179 89.6 14,187 94.3 <0.001 
Depression Treatment                     
Yes 192 12.9 1,131 7.1 <0.001 192 12.4 1,131 7.1 <0.001 
No 1,159 87.1 13,965 92.9 <0.001 1,159 87.6 13,965 92.9 <0.001 
Clinical Characteristics                     
Depression symptoms                     
Yes 67 4.6 303 2.0 0.010 67 2.1 303 2.0 0.950 
No 1,284 95.4 14,793 98.0 0.010 1,284 97.9 14,793 98.0 0.950 
Chronic Comorbidities 513 37.1 5,233 34.3 0.219 513 34.5 5,233 34.3 0.949 
Demographic 
Characteristics                     
Sex                     
Female 913 68.3 9,957 64.4 0.139 913 65.6 9,957 64.4 0.679 
Male 438 31.7 5,139 35.6 0.139 438 34.4 5,139 35.6 0.679 
Age                     
12-17 122 8.8 1,653 10.0 0.456 122 9.7 1,653 10.0 0.874 
18-24 164 13.5 1,839 12.9 0.663 164 12.7 1,839 12.9 0.869 
25-34 233 18.7 2,690 18.3 0.828 233 18.7 2,690 18.3 0.853 
35-44 248 18.7 2,657 18.5 0.882 248 19.0 2,657 18.5 0.753 
45-54 240 16.3 2,482 16.6 0.819 240 16.4 2,482 16.6 0.884 
55-64 196 13.8 2,018 13.2 0.671 196 13.3 2,018 13.2 0.901 
65+ 148 10.2 1,757 10.5 0.833 148 10.2 1,757 10.5 0.850 
Race/Ethnicity                     
White 962 67.7 10,938 70.0 0.478 962 70.6 10,938 70.0 0.826 
Black 124 10.4 1,563 11.3 0.547 124 12.0 1,563 11.3 0.657 
Hispanic 190 16.0 1,782 13.0 0.310 190 11.9 1,782 13.0 0.637 
Other 75 5.9 813 5.8 0.941 75 5.5 813 5.8 0.855 
Insurance                     
Private 878 65.3 9,520 65.2 0.958 878 66.3 9,520 65.2 0.722 
Medicaid 110 8.0 1,231 7.8 0.877 110 7.7 1,231 7.8 0.901 
Medicare 133 9.3 1,584 9.6 0.869 133 9.4 1,584 9.6 0.916 
Self Pay 112 8.5 1,000 7.4 0.506 112 7.1 1,000 7.4 0.862 
Other 118 8.8 1,761 10.0 0.616 118 9.5 1,761 10.0 0.816 
Census Region                     
Northeast 226 23.8 1,997 16.3 0.089 226 15.7 1,997 16.3 0.861 
Midwest 360 21.7 3,838 20.1 0.646 360 19.8 3,838 20.1 0.918 
South 406 33.9 5,476 39.4 0.190 406 39.8 5,476 39.4 0.924 
West 359 20.6 3,785 24.2 0.263 359 24.7 3,785 24.2 0.883 
MSA                     
Urban 1,197 93.0 13,112 89.2 0.053 1,197 89.1 13,112 89.2 0.968 
Rural 154 7.0 1,984 10.8 0.053 154 10.9 1,984 10.8 0.968 
Encounter Characteristics                     
Patient Status                     
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Established patient 572 38.2 6,301 40.2 0.505 572 38.9 6,301 40.2 0.670 
New patient 779 61.8 8,795 59.8 0.505 779 61.1 8,795 59.8 0.670 
Provider Status                     
Not the patient’s PCP 689 50.1 8,874 57.9 0.036 689 51.9 8,874 57.9 0.102 
Patient’s PCP 662 49.9 6,222 42.1 0.036 662 48.1 6,222 42.1 0.102 
Visit Type                     
Acute care 736 50.5 8,514 57.2 0.040 736 50.8 8,514 57.2 0.048 
Preventive care 615 49.5 6,582 42.8 0.040 615 49.2 6,582 42.8 0.048 
a Unweighted refers to inverse probability of treatment weighting. Percentages are survey-weighted to be 
nationally representative and may not add to 100%. 
b Weighted refers to inverse probability of treatment weighting. Percentages are weighted using the product of 
survey weights and inverse probability weights calculated from propensity scores. 
Note: Providers at or above the 95th percentile of screening rates qualify as higher-rate screeners 
 
Table 4.4 Adjusted regression results for depression diagnosis and treatment, comparing 
visits to providers who screen at higher rates to visits to providers who screen at lower rates 
 Depression Diagnosis Depression Treatment 
 OR 95% CI p-value OR 95% CI p-value 
Depression Care           
Depression Screening Rate       
Low 1.00 Ref. — 1.00 Ref. — 
High 1.96 1.55-2.48 <0.001 1.60 1.22-2.09 0.001 
Depression Diagnosis           
No    1.00 Ref. —  
Yes    12.32 8.74-17.36 <0.001 
Clinical Characteristics             
Depression Symptoms             
No 1.00 Ref. — 1.00 Ref. —  
Yes 7.94 5.33-11.85 <0.001 4.30 2.56-7.22 <0.001 
Comorbidities           
No 1.00 Ref. — 1.00 Ref. —  
Yes 1.99 1.45-2.74 <0.001 1.43 1.05-1.96 0.024 
Demographics            
Sex            
Male 1.00 Ref. — 1.00 Ref. —  
Female 1.73 1.19-2.51 0.004 1.08 0.78-1.49 0.634 
Age             
12-17 0.48 0.21-1.08 0.077 0.64 0.29-1.39 0.257 
18-24 1.00 Ref. — 1.00 Ref. —  
25-34 1.12 0.64-1.96 0.696 1.78 1.05-3.01 0.033 
35-44 1.55 0.85-2.83 0.155 1.47 0.90-2.42 0.126 
45-54 0.97 0.55-1.73 0.930 2.12 1.24-3.62 0.006 
55-64 0.78 0.44-1.39 0.397 1.24 0.70-2.23 0.462 
65+ 0.78 0.41-1.50 0.461 0.99 0.48-2.03 0.975 
Race/Ethnicity             
White 1.00 Ref. — 1.00 Ref. —  
Black 0.60 0.35-1.03 0.065 0.58 0.32-1.04 0.067 
Hispanic 0.62 0.39-0.98 0.040 0.59 0.38-0.92 0.020 
Other 0.35 0.20-0.61 <0.001 0.54 0.28-1.03 0.063 
Insurance             
Private 1.00 Ref. — 1.00 Ref. —  
Medicaid 1.62 0.99-2.65 0.054 0.88 0.55-1.41 0.604 
Medicare 2.00 1.27-3.15 0.003 1.15 0.64-2.08 0.632 
75 
Self Pay 1.09 0.52-2.27 0.824 0.69 0.36-1.36 0.286 
Other 0.99 0.62-1.56 0.952 0.86 0.54-1.39 0.541 
Census Region             
North 1.00 Ref. — 1.00 Ref. —  
Midwest 2.37 1.57-3.58 <0.001 2.00 1.34-2.99 0.001 
South 1.72 1.12-2.63 0.012 2.02 1.36-3.02 0.001 
West 2.25 1.51-3.37 <0.001 1.41 0.84-2.37 0.191 
MSA             
Rural 1.00 Ref. — 1.00 Ref. —  
Urban 0.92 0.61-1.39 0.693 1.04 0.64-1.68 0.880 
Encounter Characteristics             
Patient Status             
Established patient 1.00 Ref. — 1.00 Ref. —
New patient 1.12 0.83-1.50 0.462 1.31 1.00-1.72 0.053 
Provider Status             
Not the patient’s PCP 1.00 Ref. — 1.00 Ref. —  
Patient’s PCP 1.16 0.86-1.57 0.318 1.38 1.01-1.90 0.046 
Visit Type             
Acute care 1.00 Ref. — 1.00 Ref. —  
Preventive care 0.85 0.63-1.14 0.284 1.08 0.84-1.38 0.558 
Year 1.03 0.99-1.08 0.162 1.07 1.01-1.13 0.019 
Figure 4.2 Regression-adjusted predicted probability of depression diagnosis and treatment, 
stratified by provider screening rates 
 
Note: All estimates are adjusted for patient sex, age, race/ethnicity, insurance, census region, urban/rural 
status, any comorbid chronic condition; patient status (new or established); physician status as the patient’s 
primary care provider; visit type (preventive or acute problem); and year. Estimates for treatment are further 
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Summary of Findings 
 
Aim 1 – Examine the impact of the dependent coverage provision (DCP) of the 
Affordable Care Act on mental health service use and spending among young adults 
diagnosed with depression and anxiety, including changes in the composition of the 
population in treatment that may indicate selection effects 
 Results from this study showed an association between implementation of the DCP 
and significant increases in the probability of using mental health service among privately 
insured young adults 19-25 years old with depression and anxiety diagnoses compared to 
adults 27-33 years old who were not eligible for dependent coverage under the provision. 
Estimates for the probability of service use ranged from a 9% increase over the baseline rate 
for outpatient depression or anxiety services overall to a 29% increase over baseline for 
inpatient depression or anxiety services. The DCP was associated with relatively small 
increases in the quantity of outpatient mental health services used per person each year. 
Among young adults who used each service, estimated increases in the number of outpatient 
depression or anxiety services and psychotherapy services were each equivalent to less than 
one additional service per person each year among those who used services. With increases 
in service use, the DCP was associated with considerable increases in average annual total 
and out-of-pocket spending. Estimates for total and out-of-pocket spending among 
diagnosed individuals amounted to annual increases of $661 and $80 per person, 
respectively.    
In analyses of new enrollees into private plans, DCP implementation was associated 
with greater increases in the probability of using mental health services among young adults 
19-25 years old with depression and anxiety diagnoses compared to adults 27-33 years old. 
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Estimates for the probability of service use ranged from an 11% increase over the baseline 
rate for outpatient depression or anxiety services to a 33% increase over baseline for 
inpatient depression or anxiety services. Among new enrollees, the quantity of services used 
per person each year was largely unchanged as a result of DCP implementation; however, a 
small estimated increase in the number of outpatient depression or anxiety services 
amounted to less than half of one additional service each year among those who used 
outpatient services. Spending increases attributable to the DCP were somewhat smaller 
among new enrollees. Estimates for total and out-of-pocket spending amounted to annual 
increases of $535 and $60 per person, respectively.  
 
Aim 2 – Examine the association between the Mental Health Parity and Addiction 
Equity Act (MHPAEA) and mental health service use and spending among young 
adults diagnosed with depression and anxiety 
 This study showed an association between the MHPAEA and changes in the 
probability of using mental health services and the quantity of services used by privately 
insured adults 26-33 years old with depression and anxiety diagnoses. At the time of 
implementation, the probability of using inpatient depression or anxiety services increased 
while the probability of outpatient psychotherapy decreased. In contrast, trends in the 
probability of inpatient service use decreased after implementation while trends in the 
probability of outpatient medication management increased. In the first year after the parity 
law was implemented, changes in the probability of using services translated into small 
absolute increases in the likelihood of using inpatient (0.2%) and medication management 
services (1.3%) and a larger absolute decrease in the likelihood of using psychotherapy 
services (7.8%). With respect to the observed rates of service use in the pre-policy period, 
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the one-year effects represent a 124% increase in the likelihood of using inpatient services, a 
34% increase in the likelihood of using medication management, and a 45% decrease in the 
likelihood of using psychotherapy. In general, the quantity of outpatient services remained 
steady over the study period; however, among individuals who used outpatient medication 
management services, the average number of services used per month increased both at the 
time of implementation and in trends over the period after implementation. The estimated 
increases were small, cumulatively totaling less than one additional service per medication 
management user through the end of the study period. In the period after implementation, 
trends in total spending declined slightly, but no changes in out-of-pocket spending were 
associated with implementation. The estimated decrease for total spending was too small to 
equal an overall reduction in the first year after parity implementation, but cumulatively 
amounted to a decrease of $75 in total spending per person by the end of the study period.   
 
Aim 3 – Examine the correlates of depression care and the association between 
screening rates and depression diagnosis and treatment among visits by adolescents 
and adults to outpatient primary care settings 
 This study showed low overall depression screening rates (3.0%) among initial annual 
visits to primary care settings, although rates were higher than prior estimates that were not 
limited to visits with patients who had no visits in the previous year [112, 113]. Higher odds 
of depression screening were detected for visits with patients whose primary complaints 
were consistent with depression symptoms. Higher odds of depression diagnosis and 
treatment were detected for visits in which depression screening was conducted, and the 
association between screening and the outcomes of interest was stronger for patients with 
depression symptoms than patients with other reasons for the visit. In analyses of the 
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association between provider screening rates and depression diagnosis and treatment, results 
showed that visits by demographically and clinically similar patients to providers who screen 
at higher rates are associated with higher odds of depression diagnosis and treatment 
compared to visits to providers who screen at lower rates. 
Policy Implications 
In the second chapter, dependent coverage expansion was associated with significant 
increases in mental health service use and spending among young adults with depression and 
anxiety diagnoses; however, the quantity of services used was generally stable among newly 
enrolled young adults. These findings indicate that while individuals who gained access to 
coverage after the DCP was implemented had comparable levels of service use as individuals 
who were treated for depression and anxiety before the policy was implemented, more 
young adults used services overall. Increased rates of mental health service use could 
represent depression and anxiety treatment for needs that were unmet prior to dependent 
coverage expansion since evidence suggests many newly insured young adults were 
previously uninsured and uninsurance is associated with need for mental health care [15, 16, 
18, 20, 24, 62-66, 68, 114, 115]. Alternatively, increased rates of service use could have been 
driven by disproportionate enrollment of young adults with mental health treatment needs. 
The first possibility underscores the importance of access to continuous health coverage, 
while the second explanation signals a role for policy to combat the effects of selection into 
insurance plans.  
The ACA incorporated additional programs and requirements to offset the potential 
impact of selection effects on insurer spending. The main provision impacting large group 
insurers like those studied here was implemented incrementally between 2014 and 2016. 
Known as the “individual mandate”, this provision applied financial penalties to individuals 
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without health insurance in order to encourage healthy people to purchase insurance 
coverage [79]. Both the effect and the fate of the individual mandate are currently unclear. 
The individual mandate has been a prominent target for repeal under the legislative agenda 
of the current administration. Without the mandate, estimates based on similar health reform 
suggest that enrollment in insurance would drop and spending increases associated with 
adverse selection could be assumed directly by insurers and indirectly by beneficiaries 
through higher premiums [116]; however, the cost of adverse selection to insurers and 
beneficiaries may be lower in employer-sponsored plans than within the health insurance 
exchanges, where a healthy risk pool has not yet been attained [117]. 
Some have argued the exchanges have too few healthy young adult enrollees as a 
direct result of the DCP and proposed reforms that would allow insurers to base premiums 
on age in a way that would increase costs for older Americans and reduce costs for younger 
adults to encourage their enrollment [118]. The evidence presented here cannot support or 
refute claims about the health of young adults who gained access to employer-sponsored 
insurance as a result of the DCP relative to the remainder of young adults eligible to 
purchase health coverage on the exchanges; however, the results show that mental health 
service use and spending increased as a result of the DCP, suggesting young adults who 
benefited from the DCP were not entirely healthy. Nonetheless, treatment intensity was 
similar on average before and after the DCP was implemented, which suggests newly 
enrolled young adults did not have more severe depression and anxiety disorders.  
In the third chapter, the federal parity law (MHPAEA) was associated with modest 
changes in mental health service use among young adults with depression or anxiety 
diagnoses. In the inpatient setting, the results suggest access to hospital-based care for 
depression and anxiety might have increased initially. Over time, decreases in trends for 
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inpatient care could indicate that benefit designs deemphasized inpatient care in response to 
the initial increase or that access to ambulatory services for depression and anxiety increased 
due to more generous insurance benefits for outpatient care. In the outpatient setting, the 
results suggest greater and more frequent access to medication management services both at 
implementation and in trends over time, but an initial drop in the likelihood of using 
psychotherapy services. This variation in patterns of outpatient service use might be 
explained partially by differences across the services studied. For example, medication 
management services might have become more accessible relative to psychotherapy after the 
parity law was implemented since many psychotherapy providers do not participate in 
private insurance networks [83]. Comparative changes in generosity of insurance coverage 
could have led some individuals to choose pharmacotherapy instead of psychotherapy, as 
both can be effective outpatient treatments for depression and anxiety [4]. Changes in 
inpatient service use can also be considered relative to therapy. Previous research suggests 
privately insured individuals with depression might use psychotherapy in the acute phase and 
rely on medication in the continuation phase [84]. If psychotherapy was less accessible 
relative to other services as a result of parity requirements, then individuals with less severe 
disorders might have been more likely to use medication management or other outpatient 
services while those needing more intense treatment might have been more likely to use 
inpatient care. 
Despite evidence indicating potentially more generous benefits for some mental 
health services, increased financial protection for enrollees was not observed. Trends in total 
mental health spending decreased while out-of-pocket spending was unchanged, which could 
suggest that one of the primary goals of the parity law might not have been realized in this 
population. Alternatively, the minor spending change could suggest that cost sharing or 
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treatment limitations for depression and anxiety services were mostly compatible with parity 
requirements prior to implementation of the parity law. In that case, parity compliance might 
have been achieved through minor modifications that resulted in small shifts in service use 
without significantly impacting spending. Additionally, the availability of lower cost and 
lower intensity treatment for depression and anxiety compared to other mental illnesses 
might obscure spending changes shown in prior research on groups with more complex and 
treatment-intensive disorders [36, 37].  
Altogether, the results emphasize the potential influence of service availability and 
accessibility on treatment options used by adults with private insurance. From the payer 
perspective, substituting medication management for psychotherapy might result in savings, 
but substituting inpatient treatment of more severe disorders for psychotherapy could lead 
to large spending increases that outweigh outpatient savings. For federal parity to 
successfully increase access to care among enrollees with common mental illnesses without 
driving up spending, it could be critical to consider policies and programs to facilitate more 
efficient service use by improving the effective availability of a range of treatments. For 
example, psychiatrist participation rates in health insurance could be improved by raising 
reimbursement or implementing alternative payment models, as with the recent growth in 
team-based approaches to care [119]. 
In the fourth chapter, depression screening was uncommon in primary care settings, 
but patterns of depression care suggest screening practices were concentrated on higher risk 
patients. This difference could demonstrate targeted screening practices of physicians 
confirming a diagnosis in patients they suspect might have depression. Assuming patients 
who report depression symptoms are more likely to have depression, observing higher 
diagnosis rates in this group could be expected; however, results show the association 
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between depression symptom reporting and diagnosis depends on screening. This finding 
could reflect the better predictive accuracy of a given depression screener when applied to 
groups with higher prevalence. The finding could also indicate that depression is overlooked 
in the absence of screening, despite patient reports of symptoms consistent with depression. 
The first explanation suggests targeted screening practices could be appropriate in typical 
primary care settings where time and resources are limited, while the latter highlights the 
potential importance of increasing screening rates. Indeed, the evidence presented here 
suggests modest increases in average screening rates might lead to higher rates of depression 
identification and treatment.  
During the 10-year period studied, the USPSTF recommendations supported 
depression screening on an individual basis considering patient risk factors and clinical 
resources unless primary care practices included staff and other supports to assist depression 
diagnosis and treatment under a routine screening protocol [95, 120]. These distinctions 
were removed from recent revisions to the recommendations, which supported routine 
screening for all adolescents and adults in primary care [91]. Far from universal, the 
screening rates and relationships in this study suggest more research may be needed to 
understand which aspects of representative primary care settings are associated with higher 
screening rates. Together with more research on the relationship between screening and 
both depression care processes and patient outcomes, a greater understanding of contextual 
variation may help improve alignment between recommendations and evidence-based 




Priorities for Future Research 
National Insurance Reforms 
To understand the comprehensive effects associated with the DCP and MHPAEA 
policies, continued study over time is needed. The research presented here and the published 
literature on each policy analyzed data from 2013 or earlier, but important developments 
occurred later. As the individual mandate of the ACA imposed fees for being uninsured that 
surpassed the cost of insurance, healthier young adults might have been better represented in 
the private insurance pool [12]. Regardless of the future status of the individual mandate, 
opportunities to research the association between dependent coverage expansion and 
selection into insurance remain. Preliminary studies could examine effects from the early 
partial implementation of the individual mandate and the first year the full penalties applied. 
In addition, evidence is needed for selection into individual and small group plans.  
Individual and small group insurers face more uncertainty in relation to selection 
effects than large group insurers due to their smaller enrollee pools. Considering this 
potential disadvantage, the ACA incorporated programs and requirements to offset the 
financial impact of possible selection effects for insurers in the individual and small group 
markets [121, 122]. Implemented in 2014 and concluding at the end of 2016 when the 
individual mandate fully applied, these policies might be associated with changes in insurance 
costs. Finally, it is important to assess whether increased rates of service use diminish over 
time as the DCP functions less as a new option for young adults to obtain coverage than as a 
means for them to maintain coverage during a period associated with higher risk of losing 
access to insurance.  
Additional changes in 2014 include the application of parity requirements to nearly 
all individual and small group insurance plans, many of which formerly excluded mental 
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health and substance use disorder benefits altogether [123]. Individual and small group 
insurers face distinct financial and regulatory pressures, including variation in the state laws 
governing fully insured health plans in general and specific differences in their mental health 
parity requirements [124]. Future studies examining the relationship between the federal 
parity law and mental health service use and spending within individual and small group 
plans or across insurance categories could reveal important similarities and differences in the 
effect of parity implementation compared to changes that have been described in the 
literature on large group plans.  
 Studies of the relationship between national insurance reform and mental health care 
among groups with severe and persistent mental illnesses are also needed. Chronic and 
disabling mental disorders also have more predictable courses and treatment needs than the 
often transient disorders studied here, which amplifies the potential for adverse selection 
into insurance plans [67]. Therefore, the mechanisms by which the DCP potentially 
impacted mental health service use and spending among individuals diagnosed with severe 
and persistent mental illnesses could contrast with the evidence presented here. While 
serious mental illnesses affect considerably fewer people than less serious disorders, the cost 
of treating them may be higher, which could have important implications for the financial 
risk assumed by insurers and enrollees as a result of the DCP [125, 126].  
Some previous studies of federal parity have focused both on people with high 
intensity service use indicating more serious mental problems and on children with autism, a 
developmental disorder that commonly requires intensive and prolonged care [34, 36]; 
however, research to date has not explicitly explored the association between the MHPAEA 
and mental health care among groups with severe and persistent mental illnesses, such as 
bipolar disorders. Until recently, studying the effect of federal parity within these groups was 
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possibly constrained by small sample sizes considering severe mental illnesses are 
uncommon and individuals with severe mental illnesses were underrepresented in the private 
plans targeted by the parity law [127]. The extension of parity requirements in 2014, 
particularly to Medicaid expansion plans, enabled many vulnerable individuals with severe 
mental illness to obtain insurance with mental health benefits subject to the parity law [128]. 
Given that treatment of severe mental illnesses shapes mental health care spending, the 
potential influence of parity on service use and spending in these groups has widespread 
consequences.  
Depression Screening in Primary Care Settings 
 Opponents of universally screening adolescents and adults in primary care criticize 
the USPSTF recommendations based on insufficient evidence, specifically citing that no 
randomized control trials have assessed whether depression screening leads to lower 
prevalence rates [54]. This point is reasonable considering the USPSTF issues national 
recommendations upon which health policies are frequently based. Nonetheless, a better 
understanding of the relationships between screening and outcomes that are intermediate to 
depression remission may be needed in order to establish the linkage between depression 
screening and reduced prevalence. Identifying depression is important for treatment, and 
treatment that aligns with guidelines for both initiation and continuation is critical to achieve 
remission [41]. The research presented here suggests screening has an important role in 
identifying and treating depression in primary care, but future studies could examine this 
pathway over time in order to formally assess whether diagnosis and treatment mediate the 
relationship between depression screening and patient outcomes.  
In addition, research focusing explicitly on the association between contextual 
factors and the depression care pathway in general medical settings is needed. Current 
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evidence demonstrating successful depression treatment in general medical settings largely 
originates from clinical trials testing care coordination and collaboration models to integrate 
mental health into primary care [44]. Heterogeneity in the results of this research indicate the 
potential role of contextual effects, but less is known about depression treatment in primary 
care outside the framework of large-scale trials [44]. In particular, research is needed on the 
structure and organization of representative primary care practices and the availability and 
distribution of resources.  
Studying representative settings could facilitate the identification of common systems 
or processes that are conducive to implementing standardized elements of models for 
treating depression in primary care. For example, a recent study examined the association 
between depression screening and the adoption of electronic health record (EHR) systems in 
primary care, including utilization of specific EHR features [57]. Studies of EHR systems 
could be extended to diagnosis, treatment, and health outcomes. Corresponding studies of 
the systems used in settings without EHR could illuminate similar relationships between 
depression care and specific routines, such as using problem lists for patients [57]. In 
addition to standardization, analyzing variation in environments and resources across 
conventional settings could expose organizational and operational features suitable for 
customized strategies to address depression primary care.  
Providers and staff can serve as key informants for designing and executing studies 
of the structural aspects of primary care practices that are related to depression management 
[129]. Some data collection tools have been developed to assess organizational features of 
primary care practice, but they vary widely in terms of their measures, target populations, 
and validation [130]. A small minority of these tools explicitly address mental health care, 
and most were created and used in localized settings [130]. Surveys or interviews of primary 
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care providers in representative settings could reveal relationships that generalize to typical 
primary care practices. Finally, incorporating the training, experience, and opinions of 
providers into surveys and interviews could illuminate the perceived benefits and barriers 
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Appendix A 
Supplemental Table A-1. Baseline characteristics of young adults with depression and anxiety diagnoses before the DCP was implemented, 
stratified by sensitivity analysis 
 Narrow Sample Beneficiary Sample 
 23-25 years old 27-29 years old 19-25 dependent 19-25 primary 
 N % N % N % N % 
 48,438  74,687  66,465  53,533  
Sex         
Female 34,118 70.4 52,397 70.2 41,798 62.9 38,971 72.8 
Census Region         
Northeast 7,820 16.1 11,399 15.3 9,845 14.8 8,830 16.5 
Midwest 12,562 25.9 18,780 25.1 19,924 30.0 12,407 23.2 
South 17,793 36.7 28,531 38.2 19,607 29.5 20,527 38.3 
West 10,263 21.2 15,977 21.4 17,089 25.7 11,769 22.0 
Urban/rural         
MSA 42,712 88.2 65,964 88.3 59,224 89.1 46,868 87.5 
Diagnoses         
Depression alone 21,602 44.6 34,377 46.0 31,781 47.8 23,710 44.3 
Anxiety alone 20,117 41.5 30,311 40.6 25,832 38.9 22,524 42.1 
Depression and anxiety 6,719 13.9 9,999 13.4 8,852 13.3 7,299 13.6 
Comorbidities         
Any mental illness 10,195 21.0 14,929 20.0 17,838 26.8 10,414 19.5 
   Bipolar disorder 2,445 5.0 3,291 4.4 4,468 6.7 2,384 4.5 
   Substance use disorder 1,975 4.1 2,615 3.5 4,983 7.5 1,851 3.5 
Service use         
Any inpatient depression or anxiety service use 990 2.0 1,379 1.8 2,156 3.2 1,127 2.1 
Any outpatient depression or anxiety service use 48,209 99.5 74,383 99.6 65,913 99.2 53,295 99.6 
Average depression or anxiety services per year among users 5.99   6.02   6.12   5.48   
Any outpatient psychotherapy service use 19,815 40.9 31,803 42.6 31,741 47.8 19,653 36.7 
Average psychotherapy services per year among users 9.39   9.40   9.18   8.49   
Any outpatient medication management service use 6,707 13.8 9,723 13.0 11,903 17.9 6,219 11.6 
Average medication management services per year among users 3.48   3.48   3.39   3.31   
Any psychotropic medication use 33,820 69.8 52,625 70.5 46,336 69.7 36,513 68.2 
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Supplemental Table A-2. Estimated effects of the DCP on mental health service use and spending among young adults with depression 
and anxiety diagnoses, stratified by sensitivity analysis 
Narrow Sample 
23-25 years old 27-29 years old  
Pre-DCP Post-DCP Pre-DCP Post-DCP 
Probability of service use %b 95% CI % 95% CI % 95% CI % 95% CI DDa 95% CI p 
Inpatient or Outpatient Depression or Anxiety 6.59 6.50-6.68 8.14 8.05-8.22 7.04 6.97-7.11 7.79 7.68-7.90 0.80 0.68-0.92 <0.001 
Inpatient Depression or Anxiety 0.11 0.10-0.12 0.18 0.17-0.20 0.13 0.12-0.14 0.16 0.15-0.18 0.04 0.02-0.06 <0.001 
Outpatient Depression or Anxiety 6.57 6.48-6.66 8.10 8.02-8.19 7.02 6.95-7.09 7.76 7.65-7.87 0.80 0.67-0.92 <0.001 
Psychotherapy 2.82 2.76-2.88 3.58 3.52-3.63 3.11 3.06-3.15 3.23 3.16-3.30 0.64 0.55-0.72 <0.001 
Medication management 0.92 0.88-0.95 1.11 1.07-1.14 1.07 1.04-1.10 1.00 0.96-1.05 0.26 0.21-0.30 <0.001 
Intensity of outpatient service use among 
users N
c 95% CI N 95% CI N 95% CI N 95% CI DD 95% CI p 
Depression or anxiety 6.34 6.21-6.48 7.32 7.18-7.46 6.30 6.21-6.39 6.83 6.70-6.96 0.45 0.28-0.61 <0.001 
Psychotherapy 9.73 9.47-9.98 10.87 10.63-11.10 9.78 9.62-9.95 10.54 10.29-10.78 0.39 0.09-0.69 0.013 
Medication management 3.57 3.45-3.69 3.56 3.47-3.66 3.54 3.45-3.62 3.52 3.40-3.63 0.02 -0.12-0.15 0.821 
Mental Health Spending $d 95% CI $ 95% CI $ 95% CI $ 95% CI DD 95% CI p 
Total 1,697 1,631-1,763 2,470 2,382-2,559 1,828 1,778-1,877 1,923 1,846-2,000 678 577-778 <0.001 
Out-of-pocket 328 318-337 422 412-433 353 345-361 368 358-377 80 68-92 <0.001 
Beneficiary Sample 
19-25 Dependents 19-25 Primary  
Pre-DCP Post-DCP Pre-DCP Post-DCP 
Probability of service use %b 95% CI % 95% CI % 95% CI % 95% CI DDa 95% CI p 
Inpatient or Outpatient Depression or Anxiety 6.59 6.53-6.65 8.21 8.16-8.25 5.43 5.38-5.48 6.15 6.09-6.22 0.89 0.79-0.98 <0.001 
Inpatient Depression or Anxiety 0.17 0.17-0.18 0.28 0.27-0.28 0.11 0.11-0.12 0.13 0.12-0.14 0.09 0.07-0.10 <0.001 
Outpatient Depression or Anxiety 6.56 6.50-6.62 8.16 8.12-8.21 5.41 5.36-5.46 6.13 6.07-6.20 0.88 0.78-0.97 <0.001 
Psychotherapy 3.41 3.36-3.45 3.91 3.87-3.94 2.02 1.99-2.05 2.28 2.24-2.32 0.24 0.18-0.31 0.117 
Medication management 1.37 1.34-1.40 1.39 1.37-1.41 0.66 0.64-0.68 0.65 0.63-0.67 0.03 -0.01-0.07 0.214 
Intensity of outpatient service use among 
users N
c 95% CI N 95% CI N 95% CI N 95% CI DD 95% CI p 
Depression or anxiety 6.86 6.77-6.94 7.54 7.47-7.62 5.43 5.36-5.50 6.02 5.92-6.12 0.10 -0.05-0.25 0.530 
Psychotherapy 10.28 10.13-10.43 10.93 10.81-11.06 8.01 7.87-8.16 8.63 8.44-8.82 0.04 -0.23-0.32 0.433 
Medication management 3.59 3.52-3.65 3.52 3.47-3.57 3.24 3.17-3.32 3.15 3.07-3.23 0.03 -0.09-0.15 0.569 
Mental Health Spending $d 95% CI $ 95% CI $ 95% CI $ 95% CI DD 95% CI p 
Total 2,819 2,747-2,891 3,401 3,337-3,466 1,423 1,389-1,458 1,511 1,462-1,561 494 392-596 <0.001 
Out-of-pocket 427 419-435 510 503-516 293 288-298 324 318-331 51 39-62 <0.001 
a Difference-in-differences are regression-adjusted predictions of the interaction between age group and policy period 
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b Values are regression-adjusted predictions of percentage who used services 
c Values are regression-adjusted predictions of average services used per person per year among individuals who used services 
d Values are regression-adjusted predictions of average dollars per person per year 
Note: All regressions adjust for sex, age, census region, MSA status, age group, year, and policy period 
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Appendix B 
Supplemental Table B-1. Characteristics of newly enrolled young adults with depression and anxiety diagnoses before the DCP was 
implemented, stratified by sensitivity analysis 
 Narrow Sample  Beneficiary Sample 
 23-25 years old 27-29 years old 19-25 dependent 19-25 primary 
 N % N % N % N % 
 33,355  48,347  50,090  41,001  
Sex         
Female 23,727 71.1 34,032 70.4 31,710 63.3 30,002 73.2 
Census Region         
Northeast 5,596 16.8 7,769 16.1 7,823 15.6 6,952 17.0 
Midwest 8,409 25.2 12,054 24.9 14,771 29.5 9,593 23.4 
South 12,263 36.8 18,319 37.9 14,915 29.8 15,517 37.8 
West 7,087 21.2 10,205 21.1 12,581 25.1 8,939 21.8 
Urban/rural         
MSA 29,565 88.6 43,005 89.0 44,725 89.3 36,070 88.0 
Diagnoses         
Depression alone 14,970 44.9 22,689 46.9 24,573 49.1 18,337 44.7 
Anxiety alone 13,629 40.9 18,949 39.2 18,616 37.2 16,889 41.2 
Depression and anxiety 4,756 14.3 6,709 13.9 6,901 13.8 5,775 14.1 
Comorbidities         
Any mental illness 6,939 20.8 9,657 20.0 13,562 27.1 8,088 19.7 
   Bipolar disorder 1,725 5.2 2,267 4.7 3,609 7.2 1,975 4.8 
   Substance use disorder 1,311 3.9 1,745 3.6 3,796 7.6 1,442 3.5 
Service use         
Any inpatient depression or anxiety service use 638 1.9 792 1.6 1,427 2.8 787 1.9 
Any outpatient depression or anxiety service use 33,204 99.5 48,141 99.6 49,692 99.2 40,812 99.5 
Average depression or anxiety services per year among users 6.17   6.36   6.48   5.71   
Any outpatient psychotherapy service use 13,933 41.8 21,572 44.6 25,168 50.2 15,615 38.1 
Average psychotherapy services per year among users 9.57   9.74   9.52   8.81   
Any outpatient medication management service use 4,906 14.7 7,062 14.6 10,011 20.0 5,259 12.8 
Average medication management services per year among users 3.49   3.54   3.43   3.37   
Any psychotropic medication use 23,191 69.5 33,990 70.3 34,794 69.5 27,889 68.0 
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Supplemental Table B-2. Estimated effects of the DCP on mental health service use and spending among newly enrolled young adults with 
depression and anxiety diagnoses, stratified by sensitivity analysis 
Narrow Sample 
23-25 years old 27-29 years old  
Pre-DCP Post-DCP Pre-DCP Post-DCP 
Probability of service use %b 95% CI % 95% CI % 95% CI % 95% CI DDa 95% CI p 
Inpatient or Outpatient Depression or Anxiety 6.42 6.30-6.54 7.89 7.75-8.02 6.83 6.74-6.92 7.60 7.46-7.74 0.70 0.54-0.86 <0.001 
Inpatient Depression or Anxiety 0.11 0.10-0.12 0.18 0.16-0.20 0.12 0.11-0.14 0.17 0.14-0.19 0.03 0.00-0.06 0.008 
Outpatient Depression or Anxiety 6.39 6.28-6.51 7.85 7.72-7.98 6.81 6.72-6.91 7.57 7.43-7.71 0.70 0.54-0.86 <0.001 
Psychotherapy 2.78 2.70-2.86 3.21 3.12-3.30 2.98 2.91-3.04 3.00 2.92-3.09 0.40 0.30-0.51 <0.001 
Medication management 0.92 0.88-0.97 0.99 0.94-1.03 1.02 0.98-1.06 0.93 0.88-0.98 0.15 0.09-0.21 <0.001 
Intensity of outpatient service use among 
users N
c 95% CI N 95% CI N 95% CI N 95% CI DD 95% CI p 
Depression or anxiety 6.28 6.11-6.46 6.98 6.79-7.16 6.27 6.15-6.39 6.98 6.77-7.18 -0.01 -0.24-0.22 0.901 
Psychotherapy 9.59 9.26-9.91 10.23 9.88-10.57 9.74 9.50-9.97 10.74 10.37-11.12 -0.37 -0.79-0.06 0.114 
Medication management 3.45 3.30-3.61 3.35 3.20-3.50 3.56 3.44-3.68 3.44 3.27-3.60 0.02 -0.17-0.21 0.860 
Mental Health Spending $d 95% CI $ 95% CI $ 95% CI $ 95% CI DD 95% CI p 
Total 1,653 1,575-1,731 2,303 2,178-2,428 1,779 1,713-1,844 1,923 1,821-2,025 506 368-643 <0.001 
Out-of-pocket 332 321-344 430 415-445 354 345-364 399 385-414 53 35-71 <0.001 
Beneficiary Sample 
19-25 Dependents 19-25 Primary 
 
Pre-DCP Post-DCP Pre-DCP Post-DCP 
Probability of service use %b 95% CI % 95% CI % 95% CI % 95% CI DDa 95% CI p 
Inpatient or Outpatient Depression or Anxiety 6.49 6.43-6.56 8.26 8.19-8.32 5.22 5.16-5.27 5.66 5.58-5.74 1.32 1.20-1.44 <0.001 
Inpatient Depression or Anxiety 0.18 0.17-0.19 0.31 0.30-0.33 0.11 0.10-0.11 0.12 0.11-0.13 0.12 0.10-0.15 <0.001 
Outpatient Depression or Anxiety 6.46 6.40-6.53 8.21 8.14-8.28 5.20 5.14-5.25 5.64 5.56-5.72 1.30 1.18-1.42 <0.001 
Psychotherapy 3.31 3.26-3.35 3.72 3.68-3.77 1.97 1.94-2.00 2.04 1.99-2.08 0.35 0.27-0.43 <0.001 
Medication management 1.33 1.30-1.36 1.33 1.31-1.36 0.66 0.64-0.68 0.60 0.58-0.63 0.06 0.01-0.11 0.002 
Intensity of outpatient service use among 
users N
c 95% CI N 95% CI N 95% CI N 95% CI DD 95% CI p 
Depression or anxiety 6.78 6.68-6.88 7.35 7.24-7.45 5.40 5.32-5.48 5.88 5.75-6.01 0.08 -0.10-0.27 0.727 
Psychotherapy 10.12 9.95-10.29 10.39 10.22-10.57 8.00 7.84-8.17 8.52 8.27-8.78 -0.25 -0.60-0.09 0.060 
Medication management 3.51 3.44-3.58 3.38 3.29-3.47 3.23 3.14-3.32 3.08 2.96-3.19 0.02 -0.14-0.18 0.666 
Mental Health Spending $d 95% CI $ 95% CI $ 95% CI $ 95% CI DD 95% CI p 
Total 2,714 2,636-2,792 3,321 3,233-3,409 1,420 1,378-1,461 1,517 1,440-1,595 509 376-643 <0.001 
Out-of-pocket 434 425-433 532 521-542 291 285-297 329 320-339 60 44-76 <0.001 
a Difference-in-differences are regression-adjusted predictions of the interaction between age group and policy period 
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b Values are regression-adjusted predictions of percentage who used services 
c Values are regression-adjusted predictions of average services used per person per year among individuals who used services 
d Values are regression-adjusted predictions of average dollars per person per year 
Note: All regressions adjust for sex, age, census region, MSA status, age group, year, and policy period 
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